<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">37138</article-id><article-id pub-id-type="doi">10.7554/eLife.37138</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>Human gut <italic>Bacteroides</italic> capture vitamin B<sub>12</sub> via cell surface-exposed lipoproteins</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-109762"><name><surname>Wexler</surname><given-names>Aaron G</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-7926-089X</contrib-id><email>aaron.wexler@yale.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-109797"><name><surname>Schofield</surname><given-names>Whitman B</given-names></name><email>whitman.schofield@yale.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/><xref ref-type="fn" rid="pa1">†</xref></contrib><contrib contrib-type="author" id="author-109799"><name><surname>Degnan</surname><given-names>Patrick H</given-names></name><email>patrick.degnan@ucr.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/><xref ref-type="fn" rid="pa2">‡</xref></contrib><contrib contrib-type="author" id="author-109798"><name><surname>Folta-Stogniew</surname><given-names>Ewa</given-names></name><email>ewa.folta-stogniew@yale.edu</email><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-109800"><name><surname>Barry</surname><given-names>Natasha A</given-names></name><email>natasha.barry@yale.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-81325"><name><surname>Goodman</surname><given-names>Andrew L</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-7599-3471</contrib-id><email>andrew.goodman@yale.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution content-type="dept">Department of Microbial Pathogenesis</institution><institution>Yale University</institution><addr-line><named-content content-type="city">New Haven</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution content-type="dept">Microbial Sciences Institute</institution><institution>Yale University</institution><addr-line><named-content content-type="city">New Haven</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution content-type="dept">W.M. Keck Biotechnology Resource Laboratory</institution><institution>Yale University School of Medicine</institution><addr-line><named-content content-type="city">New Haven</named-content></addr-line><country>United States</country></aff></contrib-group><author-notes><fn fn-type="present-address" id="pa1"><label>†</label><p>Human and Translational Immunology Program, Yale University School of Medicine, New Haven, United States</p></fn><fn fn-type="present-address" id="pa2"><label>‡</label><p>Department of Microbiology and Plant Pathology, University of California Riverside, Riverside, United States</p></fn></author-notes><pub-date date-type="publication" publication-format="electronic"><day>18</day><month>09</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>7</volume><elocation-id>e37138</elocation-id><history><date date-type="received" iso-8601-date="2018-03-29"><day>29</day><month>03</month><year>2018</year></date><date date-type="accepted" iso-8601-date="2018-08-26"><day>26</day><month>08</month><year>2018</year></date></history><permissions><copyright-statement>© 2018, Wexler et al</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Wexler et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-37138-v1.pdf"/><abstract><object-id pub-id-type="doi">10.7554/eLife.37138.001</object-id><p>Human gut <italic>Bacteroides</italic> use surface-exposed lipoproteins to bind and metabolize complex polysaccharides. Although vitamins and other nutrients are also essential for commensal fitness, much less is known about how commensal bacteria compete with each other or the host for these critical resources. Unlike in <italic>Escherichia coli</italic>, transport loci for vitamin B<sub>12</sub> (cobalamin) and other corrinoids in human gut <italic>Bacteroides</italic> are replete with conserved genes encoding proteins whose functions are unknown. Here we report that one of these proteins, BtuG, is a surface-exposed lipoprotein that is essential for efficient B<sub>12</sub> transport in <italic>B. thetaiotaomicron.</italic> BtuG binds B<sub>12</sub> with femtomolar affinity and can remove B<sub>12</sub> from intrinsic factor, a critical B<sub>12</sub> transport protein in humans. Our studies suggest that <italic>Bacteroides</italic> use surface-exposed lipoproteins not only for capturing polysaccharides, but also to acquire key vitamins in the gut.</p></abstract><abstract abstract-type="executive-summary"><object-id pub-id-type="doi">10.7554/eLife.37138.002</object-id><title>eLife digest</title><p>Eating is the first step in an hours-long process that extracts the nutrients we need to live. It not only nourishes us, but also a vast community of bacteria in our gut called the microbiota. The gut microbiota acts like an extension of our immune system and helps us stay healthy in many ways. For example, it blocks pathogens from making us sick. But too many gut bacteria in the wrong parts of our intestines can be harmful.</p><p>Some people are prone to developing a dangerous overgrowth of bacteria in their small intestine where most of our dietary nutrients get absorbed. This overgrowth can lead to many problems including vitamin B12 deficiency even when they eat plenty of it. To understand why, scientists must learn how microbes affect our ability to absorb nutrients from food and how the microbes themselves capture nutrients like vitamin B12 as they pass through our digestive tract.</p><p>Now, Wexler et al. show that some gut microbes may be able to pirate vitamin B12 from us as it passes through the digestive tract. Wexler et al. showed that a protein called BtuG on the surface of a type of gut bacteria called <italic>Bacteriodes</italic> grabs onto vitamin B12 with extraordinary strength. In fact, these bacterial proteins bind to vitamin B12 so strongly that they can even pry it away from our own vitamin B12 collecting protein.</p><p>When <italic>Bacteriodes</italic> with and without BtuG were placed in mice with no gut bacteria of their own, bacteria with BtuG rapidly outcompeted those lacking the protein. The experiments suggest that competition for vitamin B12 among microbes has favored bacteria that are better at capturing the nutrient. More studies are needed to learn whether BtuG contributes to vitamin B12 deficiencies in humans with gut bacteria overgrowth and determine the best ways to combat such deficiencies.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>microbiome</kwd><kwd>intrinsic factor</kwd><kwd>gut</kwd><kwd>lipoprotein</kwd><kwd>vitamin B12</kwd><kwd>corrinoid</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Other</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>GM118159</award-id><principal-award-recipient><name><surname>Goodman</surname><given-names>Andrew L</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000861</institution-id><institution>Burroughs Wellcome Fund</institution></institution-wrap></funding-source><award-id>1014860</award-id><principal-award-recipient><name><surname>Goodman</surname><given-names>Andrew L</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000011</institution-id><institution>Howard Hughes Medical Institute</institution></institution-wrap></funding-source><award-id>55108526</award-id><principal-award-recipient><name><surname>Goodman</surname><given-names>Andrew L</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010848</institution-id><institution>Gruber Foundation</institution></institution-wrap></funding-source><award-id>Graduate Student Fellowship</award-id><principal-award-recipient><name><surname>Wexler</surname><given-names>Aaron G</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>GM103574</award-id><principal-award-recipient><name><surname>Goodman</surname><given-names>Andrew L</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>The human gut bacterial lipoprotein BtuG binds vitamin B12 with femtomolar affinity, can remove vitamin B12 from human intrinsic factor, and is required for commensal fitness in the gut.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Our understanding of the factors that shape gut microbial community composition is largely based on the primary economy of this ecosystem: the flow of carbon from the diet to bacterial biomass and fermentation products. However, an accompanying secondary economy of essential vitamins and other cofactors, which are much less abundant, also plays a critical role in determining bacterial growth rates and resulting microbiome dynamics (<xref ref-type="bibr" rid="bib51">Sonnenburg and Sonnenburg, 2014</xref>). Small molecule cofactor biosynthesis is an energetically costly process and alternate cofactor-independent enzymes can be less efficient (<xref ref-type="bibr" rid="bib43">Roth et al., 1993</xref>), favoring microbes that can best acquire these nutrients from their environment.</p><p>The complex organometallic cofactor vitamin B<sub>12</sub> (cobalamin) is representative of this challenge: de novo biosynthesis requires the coordinated activity of nearly 30 dedicated enzymes (<xref ref-type="bibr" rid="bib43">Roth et al., 1993</xref>). Although bacteria have evolved cofactor-independent alternatives to many B<sub>12</sub>-dependent enzymes (e.g. B<sub>12</sub>-independent methionine synthase MetE and ribonucleotide reductase NrdEF), even species that lack vitamin biosynthetic machinery maintain their B<sub>12</sub>-dependent enzymes (e.g., methionine synthase MetH and ribonucleotide reductase NrdZ) for use when vitamin B<sub>12</sub> is available in the environment (<xref ref-type="bibr" rid="bib15">Degnan et al., 2014a</xref>; <xref ref-type="bibr" rid="bib16">Degnan et al., 2014b</xref>; <xref ref-type="bibr" rid="bib56">Young et al., 2015</xref>). In the human gut, most species encode B<sub>12</sub>-dependent enzymes. The great majority of these species also encode transport systems for capturing B<sub>12</sub> from the environment, either instead or in addition to vitamin biosynthetic pathways (<xref ref-type="bibr" rid="bib15">Degnan et al., 2014a</xref>). Although bacteria utilize many vitamin B<sub>12</sub>-like molecules (corrinoids), transport and utilization proteins and regulatory elements are typically referred to as B<sub>12</sub>-dependent, in keeping with their initial characterization.</p><p>The machinery used by Gram-negative bacteria to transport vitamin B<sub>12</sub> and other corrinoids has been studied extensively in <italic>Escherichia coli</italic> and has been used as a model for TonB-dependent transport. In <italic>E. coli</italic>, extracellular B<sub>12</sub> is transported into the periplasm through the outer membrane β-barrel protein BtuB in a TonB-dependent manner (<xref ref-type="bibr" rid="bib5">Bassford et al., 1976</xref>; <xref ref-type="bibr" rid="bib6">Bassford and Kadner, 1977</xref>). The periplasmic protein BtuF subsequently binds to and delivers B<sub>12</sub> to the ABC-type transporter BtuCD in the inner membrane, which brings the vitamin into the cytoplasm (<xref ref-type="bibr" rid="bib9">Cadieux et al., 2002</xref>).</p><p>In previous studies, we established that the most abundant Gram-negative bacteria in the human gut (Bacteroidetes) encode a diverse array of B<sub>12</sub> transport systems in B<sub>12</sub>-riboswitch regulated loci, often with multiple locus architectures per genome (<xref ref-type="bibr" rid="bib15">Degnan et al., 2014a</xref>). <italic>Bacteroides thetaioatomicron</italic> serves as a model for defining the role of these transporters, as it does not encode B<sub>12</sub> biosynthetic machinery, and its repertoire of B<sub>12</sub> transporters determine in vivo fitness in a diet- and community context-dependent manner (<xref ref-type="bibr" rid="bib15">Degnan et al., 2014a</xref>; <xref ref-type="bibr" rid="bib26">Goodman et al., 2009</xref>). In the course of these studies, we noticed that <italic>B. thetaiotaomicron</italic> and other human gut <italic>Bacteroides</italic> also maintain a heterogeneous repertoire of additional genes, nearly all of unknown function, in these B<sub>12</sub> transport loci. <italic>E. coli</italic> also encodes additional genes within its B<sub>12</sub> transport operons (e.g., <italic>btuE</italic> is positioned between <italic>btuC</italic> and <italic>btuD</italic>), but these do not play a role in B<sub>12</sub> transport (<xref ref-type="bibr" rid="bib14">de Veaux et al., 1986</xref>; <xref ref-type="bibr" rid="bib3">Arenas et al., 2010</xref>).</p><p>Here we report that unlike BtuE in <italic>E. coli</italic>, <italic>Bacteroides</italic> accessory proteins can play a critical role in B<sub>12</sub> transport. Using the <italic>B. thetaiotaomicron</italic> homolog of a highly conserved accessory protein (BT1954; hereafter called BtuG2) as a representative, we establish that BtuG2 localizes to the cell surface, interacts with BtuB, and determines the ability of <italic>B. thetaiotaomicron</italic> to transport B<sub>12</sub> and persist in the mammalian gut. Furthermore, BtuG2 directly binds vitamin B<sub>12</sub> with femtomolar affinity, thereby enabling it to acquire this vitamin from intrinsic factor, a critical B<sub>12</sub> transport protein in humans.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Bacteroidetes <italic>btuG</italic> homologs display widespread genetic linkage to vitamin B<sub>12</sub> transport genes and facilitate cyanocobalamin acquisition</title><p>Nearly all of the <italic>Bacteroides</italic> B<sub>12</sub> transport loci include homologs of a hypothetical gene that is exclusively found in the Bacteroidetes phylum (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). We refer to these homologs as BtuG; one of which (BtuG2 from <italic>B. thetaiotaomicron</italic>, marked with a star in <xref ref-type="fig" rid="fig1">Figure 1A</xref>) has been crystallized and adopts a seven-bladed β-propeller fold (PDB 3DSM; <xref ref-type="fig" rid="fig1">Figure 1B</xref>). <italic>B. thetaiotaomicron</italic> encodes three genetic loci with vitamin B<sub>12</sub> transport genes (<italic>locus1</italic>, <italic>locus2</italic> and <italic>locus3</italic>; <xref ref-type="fig" rid="fig1">Figure 1A</xref>). Each locus encodes a <italic>btuG</italic> homolog (<italic>btuG1</italic>, <italic>btuG2</italic> and <italic>btuG3</italic>, respectively) adjacent to a homolog of <italic>btuB</italic> (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Using BtuG1, BtuG2 and BtuG3 from <italic>B. thetaiotaomicron</italic> as representatives, we identified 112 putative BtuG homologs in 313 genome-sequenced human gut bacterial strains (<xref ref-type="bibr" rid="bib15">Degnan et al., 2014a</xref>) by an initial BlastP search (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). 106 are encoded in 106 of 109 <italic>btuB</italic>-containing operons identified previously (<xref ref-type="bibr" rid="bib15">Degnan et al., 2014a</xref>). The six remaining <italic>btuG</italic> homologs identified by BlastP have operon annotations affected by incomplete genome assemblies, however, five are associated with a corrinoid riboswitch and one or more <italic>btu</italic> transport genes. Two of the three remaining <italic>btuB-</italic>containing operons encode a divergent <italic>btuG</italic> gene (e-value &gt;1e-10, but Phyre2 match to the BtuG2 crystal structure). No homologs were detected outside of the Bacteroidetes using the defined BlastP parameters (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>).</p><fig-group><fig id="fig1" position="float"><object-id pub-id-type="doi">10.7554/eLife.37138.003</object-id><label>Figure 1.</label><caption><title>BtuG homologs are exclusively found among the Bacteroidetes, facilitate the acquisition of cyanocobalamin in vitro and confer a fitness advantage in gnotobiotic mice.</title><p>(<bold>A</bold>) Genetic loci encoding corrinoid transport components in <italic>E. coli</italic>, <italic>B. thetaiotaomicron</italic> and other Bacteroidetes. (<bold>B</bold>) BtuG2 (PDB 3DSM) adopts a seven-bladed β-propeller fold. (<bold>C</bold>) Growth curves for the <italic>B. thetaiotaomicron</italic> parent strain, <italic>btuG2</italic> deletion strain or complemented strain grown in minimal media supplemented with methionine or vitamin B<sub>12</sub>. Data are representative of three independent trials; error bars indicate ±SD from three technical replicates. (<bold>D</bold>) Gene expression ratios for <italic>B. thetaiotaomicron</italic> strains grown in minimal media with methionine and indicated concentrations of vitamin B<sub>12</sub>. Expression of <italic>locus2</italic> (BT1956) was normalized first to 16S rRNA and then to each strain’s expression in 0 nM vitamin B<sub>12</sub>. Data are representative of two independent trials; error bars indicate ± SD from three biological replicates. (<bold>E, F</bold>) <italic>B. thetaiotaomicron</italic> strain ratios determined from gDNA extracted from fecal samples collected over time from gnotobiotic mice. (n.d., not detected; <italic>n</italic> = 4 mice/group; error bars indicate ± SD).</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-37138-fig1-v1"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.37138.004</object-id><label>Figure 1—figure supplement 1.</label><caption><title>A BtuG homolog is required for <italic>B. thetaiotaomicron</italic> fitness in gnotobiotic mice.</title><p><italic>B. thetaiotaomicron</italic> parent, ∆<italic>btuG2</italic> and complemented (∆<italic>btuG2 + btuG2</italic>) strain ratios determined from gDNA extracted from fecal samples of gnotobiotic mice collected over time. (<italic>n</italic> = 5 mice; error bars indicate ± SD). The fitness defect of a <italic>B. thetaiotaomicron</italic> strain lacking <italic>btuB2</italic> (<xref ref-type="fig" rid="fig1">Figure 1F</xref>) is also complemented by expression of <italic>btuB2</italic> in single copy from a heterologous chromosomal locus (<xref ref-type="bibr" rid="bib15">Degnan et al., 2014a</xref>).</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-37138-fig1-figsupp1-v1"/></fig></fig-group><p>We sought to test whether BtuG is needed for B<sub>12</sub>-dependent growth, given the near universal genetic linkage of <italic>btuG</italic> homologs to known B<sub>12</sub> transport genes. Because <italic>B. thetaiotaomicron</italic> encodes three homologous B<sub>12</sub> transport loci (and corresponding <italic>btuG</italic> genes) that complicate the ability to assign functions to specific genes, we established a simplified genetic background that lacks <italic>locus1</italic> and <italic>locus3</italic> (hereafter referred to as the <italic>B. thetaiotaomicron</italic> ‘parent’ strain). We created an in-frame, unmarked deletion of <italic>btuG2</italic> in this parent strain and tested its ability to grow in minimal media supplemented with cyanocobalamin (B<sub>12</sub>-dependent growth; <italic>B. thetaiotaomicron</italic> encodes MetH but not MetE) or methionine (B<sub>12</sub>-independent growth). We chose cyanocobalamin concentrations of 37 nM and 0.37 nM because these concentrations repress (37 nM) or activate (0.37 nM) B<sub>12</sub> riboswitches in this species (<xref ref-type="bibr" rid="bib50">Sonnenburg et al., 2005</xref>; <xref ref-type="bibr" rid="bib36">Martens et al., 2008</xref>; <xref ref-type="bibr" rid="bib15">Degnan et al., 2014a</xref>). As compared with its growth in methionine medium, the <italic>btuG2</italic> deletion strain had a ~4 hr longer lag phase in 37 nM cyanocobalamin medium and did not display any growth during 72 hr in 0.37 nM cyanocobalamin medium (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). By contrast, the parent and complemented strains grew indistinguishably in all three media.</p><p>Vitamin B<sub>12</sub> riboswitches are RNA aptamers that bind B<sub>12</sub> directly and repress downstream gene expression, providing a biosensor for intracellular levels of this cofactor (<xref ref-type="bibr" rid="bib21">Fowler et al., 2010</xref>). To determine the contribution of BtuG2 to intracellular corrinoid accumulation, we used the B<sub>12</sub> riboswitch of <italic>locus2</italic> as a biosensor. Quantification of gene expression by qRT-PCR revealed that the parent strain represses riboswitch-dependent gene expression ~70 fold in culture medium containing 37 nM cyanocobalamin as compared to medium with 0.37 nM and 0 nM cyanocobalamin. By contrast, the <italic>btuG2</italic> deletion strain fails to repress B<sub>12</sub> riboswitch-regulated gene expression in any concentration of extracellular cyanocobalamin (<xref ref-type="fig" rid="fig1">Figure 1D</xref>). These data suggest that BtuG2 contributes significantly to B<sub>12</sub> accumulation within <italic>B. thetaiotaomicron</italic> cells.</p><p>B<sub>12</sub> transport machinery encoded in <italic>locus2</italic> are critical for <italic>B. thetaiotaomicron</italic> fitness in gnotobiotic mice (<xref ref-type="bibr" rid="bib26">Goodman et al., 2009</xref>). To compare the relative contribution of BtuG2 and BtuB2 to fitness in the gut, we colonized germfree mice with a 1:1 mixture of the parent strain and ∆<italic>btuG2</italic> (<xref ref-type="fig" rid="fig1">Figure 1E</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>) or ∆<italic>btuB2</italic> (<xref ref-type="fig" rid="fig1">Figure 1F</xref>), and monitored the relative abundance of each strain in fecal samples collected over time. In both groups of mice, the parent strain dominated while the abundance of the mutant strain dropped continuously until it was no longer detected on day 24 (<xref ref-type="fig" rid="fig1">Figure 1E–F</xref>). Surprisingly, these data indicate that the absence of BtuG2 has a similarly deleterious impact on in vivo fitness as the absence of the outer membrane transporter BtuB2. Together, these studies suggest that BtuG plays a critical role in mediating <italic>B. thetaiotaomicron</italic> B<sub>12</sub> transport in the gut.</p></sec><sec id="s2-2"><title>BtuG2 is a lipoprotein that localizes to the cell surface and associates with B<sub>12</sub> transport machinery</title><p>We next sought to determine the subcellular localization of BtuG2 to better understand its role in B<sub>12</sub> transport. Aligning the first 90 amino acids of 114 homologs of BtuG (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>) using ClustalW (<xref ref-type="bibr" rid="bib33">Larkin et al., 2007</xref>) and displaying their conservation as a sequence logo (<xref ref-type="bibr" rid="bib12">Crooks et al., 2004</xref>; <xref ref-type="bibr" rid="bib47">Schneider and Stephens, 1990</xref>) revealed a number of important clues: firstly, nearly all homologs have a conserved cysteine residue within their first ~18–40 amino acids (Cys-32 of BtuG2) (<xref ref-type="bibr" rid="bib27">Inouye et al., 1983</xref>); secondly, this cysteine is preceded by a conserved lipobox-like sequence typical of lipidated proteins (VFGS in BtuG2) (<xref ref-type="bibr" rid="bib54">von Heijne, 1989</xref>); thirdly, this cysteine is followed by a conserved lipoprotein export signal or LES (MKWD in BtuG2), a feature exclusive to Bacteroidetes that allows lipoproteins to be flipped from the inner to the outer leaflet of the outer membrane (<xref ref-type="fig" rid="fig2">Figure 2A</xref>) (<xref ref-type="bibr" rid="bib34">Lauber et al., 2016</xref>). Thus, from their primary sequences alone, we predicted BtuG homologs to be surface-exposed lipoproteins.</p><fig-group><fig id="fig2" position="float"><object-id pub-id-type="doi">10.7554/eLife.37138.005</object-id><label>Figure 2.</label><caption><title>BtuG2 is a cell surface-exposed lipoprotein that interacts with the outer membrane transporter BtuB2.</title><p>(<bold>A</bold>) N-terminus of BtuG2 and sequence logo of 114 BtuG homologs reveal sequence signatures indicative of a surface-exposed lipoprotein, including a lipobox, adjacent cysteine residue and lipoprotein export signal (LES). (<bold>B</bold>) Protease degradation of BtuG2 on whole <italic>B. thetaiotaomicron</italic> cells suggests BtuG2 is surface-exposed. SusA is a periplasmic control. Data are representative of three independent trials. (<bold>C</bold>) <italic>B. thetaiotaomicron</italic> cells separated into membrane (M), cytoplasm/periplasm (C), and supernatant (S) fractions reveal that BtuG2 is predominantly associated with the membrane in parent cells, but predominantly associated with the supernatant in ∆<italic>btuB2</italic> cells. Data are representative of four independent trials. (<bold>D</bold>) In vivo pull-down of BtuG2 by TAP-tagged BtuB2 suggests an interaction with BtuB2, but not with an unrelated outer membrane β-barrel protein SusC. Data are representative of two independent trials.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-37138-fig2-v1"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.37138.006</object-id><label>Figure 2—figure supplement 1.</label><caption><title>BtuG2 lipoprotein sequence signatures are required for protein production and can be functionally replaced with N-terminal sequences from the unrelated cell surface lipoprotein SusD.</title><p>(<bold>A</bold>) Western blot of <italic>B. thetaiotaomicron</italic> whole cell lysates of parent strain and a panel of <italic>btuG2</italic> complemented strains probed with anti-BtuG2. Data are representative of three independent trials. (<bold>B</bold>) qRT-PCR of <italic>B. thetaiotaomicron</italic> strains grown in minimal media supplemented with methionine and either 37 nM or 0.37 nM vitamin B<sub>12</sub>. Data are normalized first to 16S rRNA and then to expression of ∆<italic>btuG2 + btuG2</italic> in 0.37 nM vitamin B<sub>12</sub>. Data are representative of two independent trials; error bars indicate ± SD from three biological replicates. (<bold>C</bold>) Western blot of <italic>B. thetaiotaomicron</italic> whole cell lysates of a panel of <italic>btuG2</italic> complemented strains probed with anti-BtuG2. Data are representative of two independent trials. (<bold>D</bold>) Growth curves of <italic>B. thetaiotaomicron</italic> strains grown in minimal media supplemented with methionine or indicated concentrations of vitamin B<sub>12</sub>. Data are representative of two independent trials; error bars indicate ± SD from three technical replicates; ss, signal sequence; LES, lipoprotein export signal.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-37138-fig2-figsupp1-v1"/></fig></fig-group><p>To test whether BtuG2 is indeed surface-exposed, we treated intact cells grown in minimal medium with methionine (but without cyanocobalamin) with varying concentrations of proteinase K (0–100 µg/mL), ran whole cell lysates on an SDS-PAGE gel, and probed by Western blot for BtuG2 or a periplasmically localized control protein SusA (BT3704) appended with a C-terminal HA-tag (<xref ref-type="bibr" rid="bib48">Shipman et al., 1999</xref>). While SusA was protected from protease treatment even at the highest concentration of protease, BtuG2 was progressively degraded at increasing concentrations of protease, consistent with it being surface-exposed (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). Moreover, BtuG2 associated most strongly with the membrane of fractionated <italic>B. thetaiotaomicron</italic> cells (parent strain), and was even found in the supernatant fraction, consistent with its localization to the interface of the outer membrane of the cell and the extracellular milieu (<xref ref-type="fig" rid="fig2">Figure 2C</xref>).</p><p>Alteration of these surface-localizing sequence features diminished BtuG2 stability, complicating efforts to directly assess the contribution of these sequences to protein localization (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>). Deleting the putative signal sequence (aa 2 – 31), mutating Cys-32 to alanine, or changing three residues of the LES (Lys-34, Trp-35 and Asp-36) to alanine all resulted in a lack of BtuG2 detection in whole cell lysates by Western blot, despite normal levels of transcription (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A–B</xref>). By contrast, replacing the putative signal sequence with aa 1 – 18 of the known surface-exposed lipoprotein SusD (BT1762; aa 1 – 18) (<xref ref-type="bibr" rid="bib49">Shipman et al., 2000</xref>; <xref ref-type="bibr" rid="bib25">Glenwright et al., 2017</xref>), or replacing the signal sequence and LES (BtuG2 aa 1 – 37) with the signal sequence and LES of SusD (aa 1 – 24) complemented a <italic>btuG2</italic> deletion strain both in terms of protein production and B<sub>12</sub>-dependent growth (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1C–D</xref>). These results indicate that the N-terminal residues of BtuG2 are critical for protein stability, and that these residues can be functionally replaced with the corresponding sequences from the surface-exposed lipoprotein SusD.</p><p>Given that BtuG2 exhibits sequence signatures and protease sensitivity indicative of a surface-exposed lipoprotein, is localized to the cell membrane, and contributes to B<sub>12</sub> acquisition, we hypothesized that it might interact with the outer membrane B<sub>12</sub> transporter BtuB2. Consistent with this hypothesis, we found that deletion of <italic>btuB2</italic> changes the predominant localization of BtuG2 from the membrane fraction to the culture supernatant (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). Furthermore, tandem affinity purification (TAP) of BtuB2-associated proteins in growing <italic>B. thetaiotaomicron</italic> cells readily pulls down BtuG2 (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). By contrast, TAP of an untagged strain, or of a strain with the TAP epitopes appended to an unrelated TonB-dependent outer membrane β-barrel-type transporter (SusC; BT1763) fails to pull down BtuG2. These data suggest that BtuG2 associates with known B<sub>12</sub> transport machinery.</p></sec><sec id="s2-3"><title>BtuG2 directly binds cyanocobalamin with femtomolar affinity</title><p>All components of the canonical vitamin B<sub>12</sub> transport pathway—BtuB, BtuF and BtuCD—bind cyanocobalamin directly during the process of transport from outside the cell into the periplasm and ultimately the cytoplasm. To test whether BtuG2 also binds cyanocobalamin, we expressed and purified BtuG2-10xHis in <italic>E. coli</italic>. We then took advantage of the ability of cyanocobalamin to absorb light at a wavelength of 362 nm, and aromatic amino acids within BtuG2 to absorb light at 280 nm, by performing size-exclusion chromatography with multi-angle light scattering (SEC-MALS) on BtuG2 after co-incubation with equimolar cyanocobalamin. At both wavelengths, we observed nearly identical traces corresponding to the elution volume for BtuG2, indicating that BtuG2 can directly bind cyanocobalamin in vitro (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Purified, recombinant BtuG homologs from <italic>B. vulgatus, B. uniformis</italic> and <italic>B. coprophilus</italic> (BVU2056, BACUNI04578 and BACCOPRO02032, respectively) also exhibit this function (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>).</p><fig-group><fig id="fig3" position="float"><object-id pub-id-type="doi">10.7554/eLife.37138.007</object-id><label>Figure 3.</label><caption><title>BtuG2 binds cyanocobalamin and its corrinoid precursor with femtomolar affinity.</title><p>(<bold>A</bold>) SEC-MALS traces for recombinant BtuG2 incubated with vitamin B<sub>12</sub>. BtuG2 (protein) absorbance is measured at 280 nm; vitamin B<sub>12</sub> absorbance is measured at 362 nm. Data are representative of three independent trials. (<bold>B</bold>) Kinetic rate constants and equilibrium dissociation constant for BtuG2 binding to dicyanocobinamide and cyanocobalamin determined by SPR. Data are representative of three independent trials; error represents ± SD from rate constants measured across three Biacore chip cells.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-37138-fig3-v1"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.37138.008</object-id><label>Figure 3—figure supplement 1.</label><caption><title>Cyanocobalamin binding by diverse BtuG homologs.</title><p>(<bold>A</bold>) A gene tree assembled from 114 BtuG homologs (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>) indicates the relative homology of three BtuG homologs from <italic>B. vulgatus, B. uniformis</italic> and <italic>B. coprophilus</italic> (BVU2056, BACUNI04578 and BACCOPRO02032, respectively; shown in red). (<bold>B</bold>) Purified proteins (and a no-protein control) were incubated with B<sub>12</sub>, filtered to remove free vitamin, and quantified for absorbance at 360 nm (corresponding to vitamin B<sub>12</sub> absorbance). BSA, bovine serum albumin; B<sub>12</sub>, no-protein control after B<sub>12</sub> incubation and filtering. *p&lt;0.05 for samples compared against no-protein control (<bold>B<sub>12</sub></bold>); error bars indicate ± SD from two technical replicates.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-37138-fig3-figsupp1-v1"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.37138.009</object-id><label>Figure 3—figure supplement 2.</label><caption><title>Surface electrostatic profiles of the seven-bladed β-propeller proteins BtuG2, EUBREC_1955 and MSMAS_RS11935, and the globular enzyme acetylcholinesterase.</title><p>(<bold>A</bold>) Model of surface electrostatic profile based on the crystal structure of BtuG2 (PDB 3DSM; left) reveals a largely positive electrostatic potential (blue) on the face of BtuG2 harboring the C-terminal 6xHis tag, and a largely negative electrostatic potential (red) on the opposing face, unlike the unrelated seven-bladed β-propellers EUBREC_1955 from the human gut anaerobe <italic>Eubacterium rectale</italic> (PDB 3S25; center left) and MSMAS_RS11935 from the methanogenic archeon <italic>Methanosarcina mazei</italic> (PDB 1L0Q; center right). Opposing electrostatic charge surfaces on enzymes like acetylcholinesterase (PDB 1GQR; right) are thought to aid in ligand orientation and binding during catalysis (<xref ref-type="bibr" rid="bib52">Tan et al., 1993</xref>; <xref ref-type="bibr" rid="bib22">Getzoff et al., 1983</xref>; <xref ref-type="bibr" rid="bib42">Ripoll et al., 1993</xref>). (<bold>B</bold>) Structural similarity between BtuG2 (PDB 3DSM; gold) and the β-propeller domain of MSMAS_RS11935 (PDB 1L0Q; blue) (<xref ref-type="bibr" rid="bib28">Jing et al., 2002</xref>). These domains are superimposed with a root mean square deviation of 1.75 Å.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-37138-fig3-figsupp2-v1"/></fig></fig-group><p>We then sought to determine the kinetics and affinity of cyanocobalamin binding by BtuG2. Because BtuG2-cyanocobalamin saturation occurs too rapidly to measure the dissociation constant accurately by isothermal titration calorimetry (data not shown), we used surface plasmon resonance (SPR) to determine a <italic>K</italic><sub>D</sub> of 1.87 ± 0.76 × 10<sup>−13</sup> M for BtuG2-cyanocobalamin binding and 1.93 ± 0.63 × 10<sup>−13</sup> M for BtuG2-dicyanocobinamide binding (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). Both ligands bind BtuG2 at a 1:1 ratio. BtuG2 binds to cyanocobalamin with a measured <italic>k</italic><sub>on</sub> = 1.40 ± 0.05 × 10<sup>9</sup> M<sup>−1</sup>s<sup>−1</sup> and a <italic>k</italic><sub>off</sub> = 2.59 ± 0.96 × 10<sup>−4</sup> s<sup>−1</sup>; similarly, BtuG2 binds to dicyanocobinamide with a measured <italic>k</italic><sub>on</sub> = 2.61 ± 1.56 × 10<sup>9</sup> M<sup>−1</sup>s<sup>−1</sup> and a <italic>k</italic><sub>off</sub> = 4.54 ± 1.38 × 10<sup>−4</sup> s<sup>−1</sup>. Together, these measurements establish that BtuG2 binds cyanocobalamin and a corrinoid precursor with femtomolar affinity, at a rate generally observed for diffusion-limited enzymes and proteins. This ligand interaction is maintained for over 1 hr on average before spontaneous dissociation (<xref ref-type="bibr" rid="bib11">Corzo, 2006</xref>). Notably, surface electrostatic analysis of the crystal structure of BtuG2 reveals a predominantly positive electrostatic potential on the face of BtuG2 displaying the C-terminal 6x-His tag, and a predominantly negative electrostatic potential on the opposing face (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2A</xref>). The coordinated cobalt ion of a corrinoid carries a positive charge ranging from +1 to +3, depending in part on the upper ligand (–CN, –Me, –Ado, –OH) (<xref ref-type="bibr" rid="bib40">Obeid et al., 2015</xref>). Therefore, if surface electrostatic charges on BtuG2 are involved in orienting corrinoids to facilitate protein-ligand interactions, these forces should draw the ligand into the negative electrostatic face of BtuG2.</p></sec><sec id="s2-4"><title>BtuG2 can function extracellularly as an early step in vitamin B<sub>12</sub> acquisition and confers a fitness advantage to producer cells</title><p>Because BtuG2 modulates intracellular corrinoid levels, is surface-exposed, associates with BtuB2 and binds cyanocobalamin directly, we reasoned that it might act as a critical extracellular step in the process of capturing and transporting corrinoids. To test whether BtuG2 can function extracellularly, we measured growth of <italic>btuG2</italic> mutant cells upon supplementation with supernatants from <italic>btuB2</italic> mutant cultures (this strain disproportionally partitions BtuG2 to the supernatant; <xref ref-type="fig" rid="fig2">Figure 2C</xref>). To this end, we collected, filter-sterilized, ultra-centrifuged, and concentrated culture supernatants from <italic>B. thetaiotaomicron ∆locus1 ∆locus3 ∆btuB2</italic> (or ∆<italic>locus1</italic> ∆<italic>locus3</italic> ∆<italic>btuG2</italic> as a control) strains grown to exponential phase in minimal medium lacking cyanocobalamin and supplemented with methionine. Concentrated supernatants were incubated in the presence or absence of 0.37 µM cyanocobalamin, diluted and concentrated repeatedly to remove unbound ligand and residual methionine, and introduced to recipient cells in medium lacking both cyanocobalamin and methionine.</p><p>Under these conditions, ∆<italic>btuG2</italic> recipient cells grow robustly when provided with BtuG2-containing culture supernatant that had been incubated with cyanocobalamin (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). By contrast, the same recipient strain failed to grow when provided culture supernatant from a ∆<italic>btuG2</italic> strain incubated with cyanocobalamin, or when provided BtuG2-containing culture supernatant incubated with PBS instead of cyanocobalamin (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Further, BtuG2-containing culture supernatant incubated with cyanocobalamin failed to rescue growth of recipient cells lacking corrinoid transport machinery. These data suggest that BtuG2 can function from the exterior of cells in trans to promote cyanocobalamin-dependent growth. Notably, BtuG2-6xHis purified from <italic>E. coli</italic> failed to restore cyanocoblamin-dependent growth to a ∆<italic>btuG2</italic> mutant, suggesting that lipidation or some other <italic>Bacteriodes-</italic>specific feature may be important for protein function (data not shown).</p><fig id="fig4" position="float"><object-id pub-id-type="doi">10.7554/eLife.37138.010</object-id><label>Figure 4.</label><caption><title>BtuG2 can function extracellularly as a corrinoid delivery protein and confers a fitness advantage to BtuG2 producer cells.</title><p>(<bold>A</bold>) Schematic (left) and measured CFUs (right) from an experiment in which <italic>B. thetaiotaomicron</italic> recipient cultures (∆<italic>btuG2</italic> or ∆<italic>locus1,2,3</italic>) received donor supernatant from <italic>B. thetaiotaomicron</italic> donor strains (∆<italic>btuB2</italic> or ∆<italic>btuG2</italic>), with or without vitamin B<sub>12</sub>. Recipient cultures were plated for CFUs over time. Data are representative of four independent trials; *p&lt;0.05 for black bars compared against red, yellow or blue bars; error bars indicate ± SD from two biological replicates. (<bold>B</bold>) <italic>B. thetaiotaomicron</italic> parent and ∆<italic>btuG2</italic> strains were co-cultured in minimal media supplemented with methionine or the indicated concentrations of vitamin B<sub>12</sub> and incubated at 37 ˚C anaerobically either statically (solid lines) or shaking (dotted lines). Cells were passaged into fresh media daily and strain abundances were determined by qRT-PCR using barcode-specific primers. n.d., not detected; data are representative of two independent trials; error bars indicate ± SD from three technical replicates.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-37138-fig4-v1"/></fig><p>The observation that BtuG2 can function in trans raises the possibility that this protein could act as a public good, secreted into the environment and shared across cells in the population. However, BtuG2-producing parent cells fail to rescue the cyanocobalamin-dependent growth defect of a ∆<italic>btuG2</italic> strain when the two strains are co-cultured (<xref ref-type="fig" rid="fig4">Figure 4B</xref>), suggesting that this protein primarily functions in cis. This is consistent with its localization as a membrane-bound lipoprotein (<xref ref-type="fig" rid="fig2">Figure 2</xref>) and the competitive defect of a ∆<italic>btuG2</italic> strain in the presence of parent <italic>B. thetaiotaomicron</italic> in the mouse gut (<xref ref-type="fig" rid="fig1">Figure 1E</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>).</p></sec><sec id="s2-5"><title><italic>B. thetaiotaomicron</italic> can use BtuG2 to acquire cyanocobalamin from human intrinsic factor</title><p>Because BtuG2 is surface-exposed and binds cobalamin with femtomolar affinity, we wondered if it might affect the function of human B<sub>12</sub>-binding proteins that transport this vitamin through the length of the gastrointestinal tract. Humans absorb cobalamin from their diet with the help of two carrier proteins. The first, haptocorrin, is secreted from salivary glands and binds the vitamin as it is released from food broken down in the stomach; the second, intrinsic factor (IF), is released from parietal cells in the stomach and binds cobalamin in the duodenum following the degradation of haptocorrin by host enzymes (<xref ref-type="bibr" rid="bib39">Nielsen et al., 2012</xref>). IF then carries the vitamin through several meters of intestinal tract to the distal ileum, where receptors on intestinal epithelial cells allow for the uptake of IF and its vitamin cargo (<xref ref-type="bibr" rid="bib39">Nielsen et al., 2012</xref>). As IF traverses the small intestinal lumen, it encounters increasing densities of gut microbes (from ~10<sup>3</sup> to ~10<sup>8</sup> cells/g) (<xref ref-type="bibr" rid="bib44">Scheithauer et al., 2016</xref>).</p><p>To test whether <italic>B. thetaiotaomicron</italic> can use BtuG2 to acquire vitamin B<sub>12</sub> from IF, we first incubated recombinant human IF with cyanocobalamin, diluted and concentrated repeatedly to remove unbound ligand, provided the IF-cyanocobalamin complexes to <italic>B. thetaiotaomicron</italic> cells in minimal media without exogenous cyanocobalamin or methionine, and measured culture growth over time. The parent <italic>B. thetaiotaomicron</italic> strain grew readily when provided IF-cyanocobalamin (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). By contrast, IF alone was not sufficient to allow bacterial growth, and recipient cells lacking <italic>btuG2</italic> do not grow when provided IF-cyanocobalamin. Further, the parent strain is unable to grow when provided the filtrate from the last IF-cobalamin wash step, indicating that an insignificant amount of cobalamin dissociates from IF during dilution and concentration (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). These results indicate that <italic>btuG2</italic>-encoding <italic>B. thetaiotaomicron</italic> cells are capable of acquiring cyanocobalamin from IF.</p><fig id="fig5" position="float"><object-id pub-id-type="doi">10.7554/eLife.37138.011</object-id><label>Figure 5.</label><caption><title>BtuG2 mediates vitamin B<sub>12</sub> piracy from host intrinsic factor.</title><p>(<bold>A</bold>) Schematic (left) and measured CFUs (right) from an experiment in which <italic>B. thetaiotaomicron</italic> recipient cultures (parent or ∆<italic>btuG2</italic>) received recombinant human IF with or without vitamin B<sub>12</sub>, or the filtrate from the last IF–B<sub>12</sub> wash. Recipient cultures were plated for CFUs over time. Data are representative of two independent trials; *p&lt;0.05 for black bars compared against red, yellow or blue bars; error bars indicate ± SD from two biological replicates. (<bold>B</bold>) Schematic (left) and SEC-MALS traces at 362 nm absorbance (right) of recombinant human IF and/or recombinant BtuG2 incubated with vitamin B<sub>12</sub>. 362 nm absorbance measures B<sub>12</sub>-associated proteins and each trace represents one of the four conditions illustrated in the schematic. Data are representative of two independent trials. (<bold>C</bold>) Schematic (left) and CFUs (right) from an experiment in which <italic>B. thetaiotaomicron</italic> recipient cultures (∆<italic>btuG2</italic>) received recombinant human IF with or without vitamin B<sub>12</sub> or the filtrate from the last IF–B<sub>12</sub> wash, and donor supernatant from <italic>B. thetaiotaomicron</italic> strains (∆<italic>btuB2</italic> or ∆<italic>btuG2</italic>). Recipient cultures were plated for CFUs over time. Data are representative of two independent trials; *p&lt;0.05 for black bars compared against red, yellow or blue bars; error bars indicate ± SD from two biological replicates.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-37138-fig5-v1"/></fig><p>To test whether BtuG2 acquires cobalamin from IF directly, we incubated cyanocobalamin with IF and/or recombinant BtuG2 and determined the relative amounts of the vitamin associated with each protein by SEC-MALS. As expected, incubation of BtuG2 with cyanocobalamin produces a distinct absorbance peak at 362 nm corresponding to the elution volume for BtuG2 (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). Similarly, incubation of IF with cyanocobalamin produces a 362 nm absorbance peak at the elution volume corresponding to IF. Notably, addition of BtuG2 to IF-cobalamin shifts the majority of the 362 nm absorbance to the elution volume for BtuG2 (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). This suggests that BtuG2 can directly acquire cobalamin from an IF-cobalamin complex.</p><p>We next sought to determine whether this direct transfer of cobalamin from IF to BtuG2 allows <italic>B. thetaiotaomicron</italic> to grow on cobalamin acquired from IF-cobalamin complexes. Indeed, ∆<italic>btuG2</italic> recipient cells grow readily when provided ∆<italic>btuB2</italic> culture supernatants supplemented with IF-cobalamin complexes (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). The same recipient cells do not grow when provided ∆<italic>btuG2</italic> culture supernatants supplemented with IF-cobalamin complexes, when provided ∆<italic>btuB2</italic> culture supernatants supplemented with IF alone, or when provided ∆<italic>btuB2</italic> culture supernatants supplemented with the filtrate from the last wash of IF-cobalamin complexes (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). Collectively, these results suggest that <italic>B. thetaiotaomicron</italic> can use BtuG2 to acquire cobalamin that is already bound to the host protein responsible for transporting this vitamin through the gastrointestinal tract.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Early studies documenting increased vitamin requirements for germfree animals suggested that the microbiota plays a critical role in contributing these essential cofactors to the host (<xref ref-type="bibr" rid="bib4">Barnes, 1967</xref>). In the case of vitamin B<sub>12</sub>, however, it is unlikely that the microbiota makes a significant contribution to host vitamin supply. Indeed, B<sub>12</sub> constitutes less than 2% of fecal corrinoid pools in humans, and supplementation studies suggest that gut microbes efficiently convert dietary B<sub>12</sub> into alternate corrinoids that cannot be used by humans (<xref ref-type="bibr" rid="bib1">Allen and Stabler, 2008</xref>). In this report, we describe a novel microbial factor, BtuG, that could pose a more direct obstacle to the host’s absorption of this essential vitamin.</p><p>What evolutionary forces drove the Bacteroidetes, unlike other Gram-negative phyla, to incorporate an additional component into their B<sub>12</sub> transport pathway that binds B<sub>12</sub> with such high affinity? One possible answer lies in the gut environment, where bacteria co-exist at densities of 10<sup>11</sup> cells per gram or higher (<xref ref-type="bibr" rid="bib55">Whitman et al., 1998</xref>). Under these conditions, adaptations that increase corrinoid capture could allow cells to minimize their requirement for energetically costly vitamin biosynthetic pathways. Indeed, many human gut Bacteroidetes encode incomplete vitamin B<sub>12</sub> biosynthesis pathways; <italic>B. thetaiotaomicron</italic> is missing this pathway entirely. Selection for increased corrinoid binding affinity in BtuG could conversely permit mutations that decrease the ability of BtuB to directly capture these molecules from the environment: <italic>E. coli,</italic> which transports B<sub>12</sub> via BtuB and lacks any BtuG homolog, grows readily on 0.4 nM B<sub>12</sub> (<xref ref-type="bibr" rid="bib17">Di Girolamo et al., 1971</xref>), while <italic>B. thetaiotaomicron</italic> requires BtuG under these conditions (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). An additional consequence of selection for increased corrinoid binding affinity in BtuG is that such adaptations allow this protein to compete with the host proteins for dietary cobalamin. In this way, the ability of BtuG to acquire B<sub>12</sub> from IF may have emerged as a byproduct of inter-microbial competition for gut corrinoids. Notably, BtuG has evolved this femtomolar affinity for B<sub>12</sub> while still maintaining the capacity to release the vitamin for transport into the cell.</p><p>Gut bacteria can interfere with host cobalamin absorption in patients with small intestinal overgrowth of bacteria, leading to cobalamin deficiency (<xref ref-type="bibr" rid="bib23">Giannella et al., 1971</xref>). Early efforts to find the responsible bacteria using radiolabeled cyanocobalamin reported that <italic>Bacteroides</italic> were particularly adept at removing cyanocobalamin from IF in vitro (<xref ref-type="bibr" rid="bib24">Giannella et al., 1972</xref>; <xref ref-type="bibr" rid="bib45">Schjönsby et al., 1973</xref>). Other studies describe patients with small intestinal bacterial overgrowth whose cobalamin deficiency was corrected by antibiotics that target <italic>Bacteroides</italic> but not <italic>Proteobacteria</italic> (<xref ref-type="bibr" rid="bib46">Schjönsby et al., 1977</xref>); however, the precise factors responsible for these phenomena were never defined. Our data suggest that BtuG, which is universally present among the <italic>Bacteroides</italic>, could be one extracellular factor responsible for these observations. Although BtuG-mediated vitamin piracy may be well tolerated by a healthy host, conditions of small intestinal bacterial overgrowth or diminished IF production could alter this effect. Notably, even minor B<sub>12</sub> deficiencies (historically assigned to the ‘subclinical’ range) could have health consequences (<xref ref-type="bibr" rid="bib37">McCaddon, 2013</xref>; <xref ref-type="bibr" rid="bib38">Moore et al., 2012</xref>).</p><p>A comparison of measured binding kinetics of BtuG2 and IF may explain how this bacterial protein extracts cobalamin from IF, which also binds the vitamin very strongly. Reported equilibrium dissociation constants for IF and cobalamin span a broad range (<italic>K</italic><sub>D</sub> ~10<sup>−9</sup>–10<sup>−15</sup> M); the most extreme of these describes a <italic>K</italic><sub>D</sub> ~5 × 10<sup>−15</sup> M, a <italic>k</italic><sub>on</sub> ~7 × 10<sup>7</sup> M<sup>−1</sup>s<sup>−1</sup> and a <italic>k</italic><sub>off</sub> ~4 × 10<sup>−7</sup> s<sup>−1</sup> (<xref ref-type="bibr" rid="bib19">Fedosov et al., 2005</xref>; <xref ref-type="bibr" rid="bib8">Brada et al., 2001</xref>; <xref ref-type="bibr" rid="bib20">Fedosov et al., 2006</xref>). By comparison, BtuG2 has a <italic>K</italic><sub>D</sub> ~2 × 10<sup>−13</sup> M, a <italic>k</italic><sub>on</sub> ~1 × 10<sup>9</sup> M<sup>−1</sup>s<sup>−1</sup> and a <italic>k</italic><sub>off</sub> ~3 × 10<sup>−4</sup> s<sup>−1</sup> (<xref ref-type="fig" rid="fig3">Figure 3B</xref>). This <italic>k</italic><sub>on</sub> rate, which is similar to that previously measured in diffusion-limited enzymes and proteins (<xref ref-type="bibr" rid="bib11">Corzo, 2006</xref>), is orders of magnitude greater than the <italic>k</italic><sub>on</sub> for IF. This suggests that BtuG2 has a superior ability to bind up free cobalamin compared with IF.</p><p>The different environments in which these proteins encounter free cobalamin could explain these differences in <italic>k</italic><sub>on</sub> rates. In humans, IF first encounters free cobalamin in the duodenum, where the vitamin is released from haptocorrin by host enzymes. At this juncture, there are few gut microbes present (~10<sup>3</sup> per gram) to compete with IF for free cobalamin (<xref ref-type="bibr" rid="bib44">Scheithauer et al., 2016</xref>). By contrast, microbial densities in the large intestine exceed 10<sup>11</sup> per gram, thus introducing a stronger element of competition for free corrinoids among gut microbes (<xref ref-type="bibr" rid="bib55">Whitman et al., 1998</xref>). Therefore, BtuG2 may face a stronger selective pressure to augment its <italic>k</italic><sub>on</sub> rate in order to remain competitive against other BtuG homologs in the microbiota.</p><p>The <italic>k</italic><sub>off</sub> rate of IF is orders of magnitude lower than the <italic>k</italic><sub>off</sub> rate of BtuG2, corresponding to an average protein–ligand association time of ~700 hr for IF–cobalamin versus ~1 hr for BtuG2–cobalamin. Although both of these proteins bind B<sub>12</sub> for delivery to their respective receptor, their different tasks may explain the observed <italic>k</italic><sub>off</sub> rates. IF binds cobalamin in the proximal small intestine (duodenum), but its uptake receptors on epithelial cells are located exclusively in the distal small intestine (ileum). Therefore, IF must maintain its association with cobalamin while traversing several meters of intestinal tract before the host can absorb its nutrient cargo. By contrast, BtuG2 localizes to the bacterial cell surface and likely acts in cis to capture extracellular corrinoids for subsequent delivery to the outer membrane receptor BtuB on the same cell. This difference in protein function may impose differences in selective pressure for <italic>k</italic><sub>off</sub> rates.</p><p>Although BtuG2 and IF thus achieve these strong binding affinities by different kinetics, mixing the proteins results in a transfer of cobalamin from IF to BtuG2 (<xref ref-type="fig" rid="fig5">Figure 5</xref>). It is unclear whether this occurs through a direct interaction between BtuG2 and IF. Diffusion-limited enzymes and proteins (e.g., acetylcholinesterase and superoxide dismutase) can employ surface electrostatic charges to affect the fluid environment in their immediate vicinity in ways that can enhance the likelihood of protein–ligand contact beyond the frequency determined through diffusion alone (<xref ref-type="bibr" rid="bib52">Tan et al., 1993</xref>; <xref ref-type="bibr" rid="bib22">Getzoff et al., 1983</xref>). Acetylcholinesterase, for example, exhibits contrasting electrostatic charge distributions on opposing faces of the enzyme, creating an electrostatic dipole that is reported to drive the interaction between the enzyme and its positively charged ligand (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2A</xref>) (<xref ref-type="bibr" rid="bib42">Ripoll et al., 1993</xref>; <xref ref-type="bibr" rid="bib52">Tan et al., 1993</xref>). BtuG2 also presents one face with a predominantly positive electrostatic potential and the other with a strikingly negative electrostatic potential (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2A-B</xref>). While the β-propeller structure of BtuG2, which resembles a disk with a central hole, may contribute to the formation of a dipolar electrostatic field through the middle of the protein, these properties are not intrinsic to seven-bladed β-propeller proteins (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2A-B</xref>). Because the coordinated cobalt ion of corrinoids carries a positive charge, surface electrostatic charges could be involved in orienting free corrinoids to facilitate protein–ligand interactions by repelling corrinoids away from the positive electrostatic face while drawing them into the negative electrostatic face of BtuG2. This uncommon surface electrostatic charge distribution in BtuG2 could potentially alter IF–cobalamin stability without direct interaction between the two proteins.</p><p>Although our evidence of BtuG lipidation is indirect, the use of cell surface-level machinery to enhance the uptake of key nutrients is not unprecedented for gut microbes. For example, the <italic>Bacteroides</italic> each encode dozens of Sus-like systems, defined by the presence of an outer membrane β-barrel protein (e.g. SusC), a cell surface-exposed lipoprotein (e.g., SusD), and other components that directly interact to digest and import various polysaccharides into the cell (<xref ref-type="bibr" rid="bib32">Koropatkin et al., 2012</xref>; <xref ref-type="bibr" rid="bib25">Glenwright et al., 2017</xref>). Our studies suggest that surface-exposed nutrient binding proteins may determine the ability of these bacteria to not only capture carbon, but also to drive the ‘secondary economy’ of critical vitamins that power microbial growth in the gut.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th>Reagent type (species) <break/>or resource</th><th>Designation</th><th>Source or reference</th><th valign="top">Identifiers</th><th valign="top">Additional <break/>information</th></tr></thead><tbody><tr><td valign="top">Strain, strain <break/>background (<italic>E. coli</italic>)</td><td valign="top">S17-1 lambda pir</td><td valign="top">PMID_6340113</td><td valign="top"/><td valign="top"><italic>thi pro hdsR hdsM + recA</italic>, <break/>chromosomal <break/>insertion of <break/>RP4-2(Tc::Mu Km::Tn7), <break/>Amp<sup>S</sup></td></tr><tr><td valign="top">Strain, strain <break/>background (<italic>E. coli</italic>)</td><td valign="top">BL21 Rosetta (DE3)</td><td valign="top">Novagen</td><td valign="top"/><td valign="top">F<sup>-</sup> ompT hsdS<sub>B</sub>(r<sub>B</sub><sup>-</sup> m<sub>B</sub><sup>-</sup>) <break/><italic>gal dcm</italic> (DE3) <break/>pRARE (Cam<sup>R</sup>)</td></tr><tr><td valign="top">Strain, strain <break/>background <break/>(<italic>Bacteroides</italic> <break/> <italic>thetaiotaomicron</italic>)</td><td valign="top">VPI-5482 ∆<italic>tdk</italic></td><td valign="top">PMID_18611383</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Strain, strain <break/>background <break/>(<italic>B. thetaiotaomicron</italic>)</td><td valign="top">VPI-5482 <italic>∆tdk ∆locus1 ∆locus3</italic></td><td valign="top">PMID_24439897</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Strain, strain <break/>background <break/>(<italic>B. thetaiotaomicron</italic>)</td><td valign="top">VPI-5482 <italic>∆tdk ∆locus1 ∆btuG2 ∆locus3</italic></td><td valign="top">This paper</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Strain, strain <break/>background <break/>(<italic>B. thetaiotaomicron</italic>)</td><td valign="top">VPI-5482 <italic>∆tdk ∆locus1 ∆btuB2 ∆locus3</italic></td><td valign="top">PMID_24439897</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Strain, strain <break/>background <break/>(<italic>B. thetaiotaomicron</italic>)</td><td valign="top">VPI-5482 <italic>∆tdk ∆locus1 ∆locus2 ∆locus3</italic></td><td valign="top">PMID_24439897</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Strain, strain <break/>background <break/>(<italic>B. thetaiotaomicron</italic>)</td><td valign="top"><italic>VPI-5482 ∆tdk ∆locus1 ∆locus3 att::pNBU2_tet_BC01</italic></td><td valign="top">This paper</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Strain, strain <break/>background <break/>(<italic>B. thetaiotaomicron</italic>)</td><td valign="top"><italic>VPI-5482 ∆tdk ∆locus1 ∆btuG2 ∆locus3 att::pNBU2_tet_BC14</italic></td><td valign="top">This paper</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Strain, strain <break/>background <break/>(<italic>B. thetaiotaomicron</italic>)</td><td valign="top"><italic>VPI-5482 ∆tdk ∆locus1 ∆btuB2 ∆locus3 att::pNBU2_tet_BC14</italic></td><td valign="top">This paper</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Strain, strain <break/>background <break/>(<italic>B. thetaiotaomicron</italic>)</td><td valign="top"><italic>VPI-5482 ∆tdk ∆locus1 ∆btuG2 ∆locus3 att::pNBU2_tet_BC16_us1957_btuG2</italic></td><td valign="top">This paper</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Strain, strain <break/>background (<italic>E. coli</italic>)</td><td valign="top"><italic>BL21 Rosetta (DE3)</italic> <break/> <italic>pET21_NESG_btuG2</italic></td><td valign="top">This paper</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Strain, strain <break/>background (<italic>E. coli</italic>)</td><td valign="top"><italic>BL21 Rosetta (DE3) pET21_NESG_btuG2_10xHis</italic></td><td valign="top">This paper</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Strain, strain <break/>background (<italic>E. coli</italic>)</td><td valign="top"><italic>BL21 Rosetta (DE3) pET21_NESG_BVU2056</italic></td><td valign="top">This paper</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Strain, strain <break/>background (<italic>E. coli</italic>)</td><td valign="top"><italic>BL21 Rosetta (DE3) pET21_NESG_BACUNI04578</italic></td><td valign="top">This paper</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Strain, strain <break/>background (<italic>E. coli</italic>)</td><td valign="top"><italic>BL21 Rosetta (DE3) pET21_NESG_BACCOPRO02032</italic></td><td valign="top">This paper</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Recombinant <break/>DNA reagent</td><td valign="top">pExchange-tdk</td><td valign="top">PMID: 18611383</td><td valign="top"/><td valign="top">plasmid</td></tr><tr><td valign="top">Recombinant <break/>DNA reagent</td><td valign="top">pExchange_<italic>tdk</italic>_∆<italic>btuG2</italic></td><td valign="top"/><td valign="top"/><td valign="top">plasmid</td></tr><tr><td valign="top">Recombinant <break/>DNA reagent</td><td valign="top">pNBU2_ermG</td><td valign="top">PMID: 18611383</td><td valign="top"/><td valign="top">plasmid</td></tr><tr><td valign="top">Recombinant <break/>DNA reagent</td><td valign="top">pNBU2_ermG_us1957</td><td valign="top">This paper</td><td valign="top"/><td valign="top">plasmid</td></tr><tr><td valign="top">Recombinant <break/>DNA reagent</td><td valign="top">pNBU2_tet_BC01</td><td valign="top">PMID: 18996345</td><td valign="top"/><td valign="top">plasmid</td></tr><tr><td valign="top">Recombinant <break/>DNA reagent</td><td valign="top">pNBU2_tet_BC14</td><td valign="top">PMID: 18996345</td><td valign="top"/><td valign="top">plasmid</td></tr><tr><td valign="top">Recombinant <break/>DNA reagent</td><td valign="top">pNBU2_tet_BC16</td><td valign="top">PMID: 24439897</td><td valign="top"/><td valign="top">plasmid</td></tr><tr><td valign="top">Recombinant <break/>DNA reagent</td><td valign="top">pNBU2_erm_us1957_btuG2_C32A</td><td valign="top">This paper</td><td valign="top"/><td valign="top">plasmid</td></tr><tr><td valign="top">Recombinant <break/>DNA reagent</td><td valign="top">pNBU2_erm_us1957_btuG2_∆ss</td><td valign="top">This paper</td><td valign="top"/><td valign="top">plasmid</td></tr><tr><td valign="top">Recombinant <break/>DNA reagent</td><td valign="top">pNBU2_erm_us1957 <break/>_btuG2_K34A W35A D36A</td><td valign="top">This paper</td><td valign="top"/><td valign="top">plasmid</td></tr><tr><td valign="top">Recombinant <break/>DNA reagent</td><td valign="top">pNBU2_erm_us1957_btuG2_susD-ss</td><td valign="top">This paper</td><td valign="top"/><td valign="top">plasmid</td></tr><tr><td valign="top">Recombinant <break/>DNA reagent</td><td valign="top">pNBU2_erm_us1957_btuG2_susD-ss-LES</td><td valign="top">This paper</td><td valign="top"/><td valign="top">plasmid</td></tr><tr><td valign="top">Recombinant <break/>DNA reagent</td><td valign="top">pNBU2_erm_us1957_btuB2_FLAG_HA</td><td valign="top">This paper</td><td valign="top"/><td valign="top">plasmid</td></tr><tr><td valign="top">Recombinant <break/>DNA reagent</td><td valign="top">pNBU2_erm_us1957 <break/>_BT1763_FLAG_HA</td><td valign="top">This paper</td><td valign="top"/><td valign="top">plasmid</td></tr><tr><td valign="top">Recombinant <break/>DNA reagent</td><td valign="top">pNBU2_erm_us1957 <break/>_BT3704_HA</td><td valign="top">This paper</td><td valign="top"/><td valign="top">plasmid</td></tr><tr><td valign="top">Recombinant <break/>DNA reagent</td><td valign="top">pET21_NESG_btuG2</td><td valign="top">Northeast <break/>Structural Genomics <break/>Consortium; PDB 3DSM</td><td valign="top"/><td valign="top">plasmid</td></tr><tr><td valign="top">Recombinant <break/>DNA reagent</td><td valign="top">pET21_NESG_btuG2_10xHis</td><td valign="top">This paper</td><td valign="top"/><td valign="top">plasmid</td></tr><tr><td valign="top">Recombinant <break/>DNA reagent</td><td valign="top">pET21_NESG_BVU2056</td><td valign="top">This paper</td><td valign="top"/><td valign="top">plasmid</td></tr><tr><td valign="top">Recombinant <break/>DNA reagent</td><td valign="top">pET21_NESG_ <break/>BACUNI04578</td><td valign="top">This paper</td><td valign="top"/><td valign="top">plasmid</td></tr><tr><td valign="top">Recombinant <break/>DNA reagent</td><td valign="top">pET21_NESG_ <break/>BACCOPRO02032</td><td valign="top">This paper</td><td valign="top"/><td valign="top">plasmid</td></tr></tbody></table></table-wrap><sec id="s4-1"><title>Bacterial culture conditions</title><p>Culturing of <italic>Bacteroides thetaiotaomicron</italic> VPI-5482 was carried out in an anaerobic chamber (Coy Laboratory Products, Grass Lake, MI, USA), filled with 70% N<sub>2</sub>, 20% CO<sub>2</sub>, and 10% H<sub>2</sub> by volume, using minimal media with vitamin B<sub>12</sub> omitted (<xref ref-type="bibr" rid="bib36">Martens et al., 2008</xref>) supplemented where specified with 500 µM DL-methionine and/or vitamin B<sub>12</sub> (0, 0.37 or 37 nM). <italic>Escherichia coli</italic> S17-1 lambda <italic>pir</italic> or BL21 Rosetta (DE3) strains were grown in LB medium and incubated aerobically at 37°C. Culture media were supplemented with antibiotics as needed at the following concentrations: ampicillin 100 μg/mL, chloramphenicol 30 µg/mL, erythromycin 25 μg/mL, gentamicin 200 μg/mL, tetracycline 2 μg/mL, and 5-fluoro-2′-deoxyuridine (FUdR) 200 μg/mL.</p></sec><sec id="s4-2"><title>Genetic techniques</title><p>Plasmid constructs (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>) were created, maintained and transformed using standard molecular cloning procedures. Primers (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>) were obtained from the Keck Biotechnology Resource Laboratory (Yale University, New Haven, CT, USA) and DNA amplification was performed using KAPA HiFi ReadyMix (Kapa Biosystems, Wilmington, MA, USA). Gene deletions in <italic>B. thetaiotaomicron</italic> were carried out as previously reported using <italic>B. thetaiotaomicron</italic> ∆<italic>tdk</italic> ∆<italic>locus1</italic> ∆<italic>locus3</italic> as a parent strain (<xref ref-type="bibr" rid="bib15">Degnan et al., 2014a</xref>) by amplifying flanking regions (~1000 bp) of genes of interest and joining them by splicing by overlap extension (SOE) PCR or Gibson assembly. The concatenated fragments were inserted into the suicide vector pExchange-tdk (<xref ref-type="bibr" rid="bib36">Martens et al., 2008</xref>) via ligation or Gibson assembly. Clones were sequence-verified and introduced into <italic>B. thetaiotaomicron</italic> ∆<italic>tdk</italic> ∆<italic>locus1</italic> ∆<italic>locus3</italic> by conjugation. Following counter selection, gene deletions were confirmed by PCR. Gene complementation constructs were created using pNBU2 vectors (with or without oligonucleotide barcodes) introduced in single copy into <italic>B. thetaiotaomicron</italic> as previously described (<xref ref-type="bibr" rid="bib36">Martens et al., 2008</xref>). Complementation constructs contained 425 bp upstream of BT1957, the first gene in <italic>locus2</italic>, to capture the <italic>locus2</italic> promoter and vitamin B<sub>12</sub> riboswitch (<italic>us1957</italic>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>).</p></sec><sec id="s4-3"><title>Comparative genomics and computational analyses</title><sec id="s4-3-1"><title>Identification of BtuG homologs</title><p>BlastP searches were carried out with BT1490, BT1954 and BT2095 as queries against the predicted proteomes of 313 human gut bacteria (<xref ref-type="bibr" rid="bib15">Degnan et al., 2014a</xref>) and e-value cutoff of 1e-10. Results were collated, de-replicated and BtuG homologs assigned to <italic>btuB</italic>-containing operons described previously (<xref ref-type="bibr" rid="bib15">Degnan et al., 2014a</xref>). <italic>btuB</italic>-containing operons without a <italic>btuG</italic> homolog and <italic>btuG-</italic>containing operons without a previously characterized <italic>btuB</italic> gene were manually inspected using BlastP and Phyre2 (<xref ref-type="bibr" rid="bib2">Altschul et al., 1990</xref>; <xref ref-type="bibr" rid="bib31">Kelley and Sternberg, 2009</xref>).</p></sec><sec id="s4-3-2"><title>BtuG sequence logo</title><p>The first 90 amino acids of 114 BtuG homologs (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>) were aligned in ClustalW (<xref ref-type="bibr" rid="bib33">Larkin et al., 2007</xref>). Their sequence conservation was displayed via sequence logo (<xref ref-type="bibr" rid="bib12">Crooks et al., 2004</xref>; <xref ref-type="bibr" rid="bib47">Schneider and Stephens, 1990</xref>).</p></sec><sec id="s4-3-3"><title>BtuG gene tree</title><p>A multiple sequence alignment of 114 homologs of BtuG2 (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>) was generated in MAFFT (<xref ref-type="bibr" rid="bib30">Katoh et al., 2002</xref>) and converted into a gene tree using FigTree.</p></sec><sec id="s4-3-4"><title>Protein surface electrostatic analysis</title><p>PDB 3DSM, 3S25, 1L0Q and 1GQR were converted to PQR files using the PDB2PQR server under default settings (<xref ref-type="bibr" rid="bib18">Dolinsky et al., 2004</xref>). The resulting surface electrostatic profiles were then analyzed and viewed using an adaptive Poisson-Boltzmann solver (APBS) in PyMOL.</p></sec><sec id="s4-3-5"><title>Protein structure overlay</title><p>The crystal structures of BtuG2 (PDB 3DSM) and the N-terminal domain of the <italic>M. mazei</italic> S-layer protein MSMAS_RS11935 (PDB 1L0Q, Chain A; <xref ref-type="bibr" rid="bib28">Jing et al., 2002</xref>) were aligned by super-positioning of the C-alpha backbones using the TOPP program in the CCP4 protein crystallography suite (<xref ref-type="bibr" rid="bib35">Lu, 1996</xref>), Collaborative Computational Project Number 4, 1994). Images were prepared using Chimera (<xref ref-type="bibr" rid="bib41">Pettersen et al., 2004</xref>).</p></sec></sec><sec id="s4-4"><title>Growth curves</title><p>Overnight cultures of <italic>B. thetaiotaomicron</italic> strains grown in minimal medium supplemented with methionine (no B<sub>12</sub>) were pelleted, washed three times in minimal medium without methionine or vitamin B<sub>12</sub>, and used to inoculate wells of a 96-well plate in triplicate containing minimal media with methionine or vitamin B<sub>12</sub> (0, 0.37 or 37 nM). The plate was incubated anaerobically under constant agitation for 72 hr at 37˚C and OD600 measurements were taken at regular intervals using a BioTek Eon microplate spectrophotometer.</p></sec><sec id="s4-5"><title>In vitro bacterial competitions</title><p><italic>B. thetaiotaomicron</italic> strains carrying unique oligonucleotide barcodes were co-cultured in minimal media in triplicate as previously described (<xref ref-type="bibr" rid="bib15">Degnan et al., 2014a</xref>; <xref ref-type="bibr" rid="bib36">Martens et al., 2008</xref>). Briefly, <italic>B. thetaiotaomicron</italic> strains were grown overnight in minimal media supplemented with methionine, washed and resuspended in minimal media without methionine or vitamin B<sub>12</sub>. OD600 was measured and used to create a 1:10 mixture of competing strains (1 part parent strain to 10 parts ∆<italic>btuG2</italic> strain), which was then used to inoculate, at 1:1000, minimal media supplemented with methionine or vitamin B<sub>12</sub> (0, 0.37, or 37 nM). These inoculations were then incubated anaerobically at 37 ˚C under static conditions or shaking (250 rpm). Cultures were passaged at 1:1000 into fresh media every 24 hr and an aliquot was stored at −20 ˚C for gDNA extraction (<xref ref-type="bibr" rid="bib53">Truett et al., 2000</xref>). Relative strain abundances were determined by quantitative PCR (qPCR) using a CFX96 thermocycler (Bio-Rad, Hercules, CA, USA) and SYBR FAST Universal Mastermix (KAPA Biosystems, Wilmington, MA, USA) (<xref ref-type="bibr" rid="bib15">Degnan et al., 2014a</xref>). Strain abundances were analyzed using a standard curve and efficiency-corrected ∆Cq method was used to determine relative fold changes (<xref ref-type="bibr" rid="bib7">Bookout et al., 2006</xref>).</p></sec><sec id="s4-6"><title>Gnotobiotic animal studies</title><p>All animal experiments were performed using protocols approved by the Yale University Institutional Animal Care and Use Committee. Male and female germfree 8- to 12-week-old Swiss Webster mice were individually caged and maintained in flexible plastic gnotobiotic isolators with a 12 hr light/dark cycle. Mice were provided with standard autoclaved mouse chow (5K67 LabDiet; Purina, St. Louis, MO, USA) <italic>ad libitum</italic>. Germfree mice were colonized with 200 µL bacterial glycerol stocks by oral gavage. Mice were divided into groups (<italic>n</italic> = 4 – 5/group). Each mouse in the first group was gavaged with 10<sup>8</sup> CFU each of <italic>B. thetaiotaomicron</italic> ∆<italic>tdk</italic> ∆<italic>locus1</italic> ∆<italic>locus3 att1</italic>::pNBU2_tetQ_BC01 (‘parent’ strain) and <italic>B. thetaiotaomicron</italic> ∆<italic>tdk</italic> ∆<italic>locus1</italic> ∆<italic>locus3</italic> ∆<italic>btuG2 att1</italic>::pNBU2_tetQ_BC14 (‘∆<italic>btuG2</italic>’ strain). Each mouse in the second group was gavaged with 10<sup>8</sup> CFU each of the parent strain and <italic>B. thetaiotaomicron</italic> ∆<italic>tdk</italic> ∆<italic>locus1</italic> ∆<italic>locus3</italic> ∆<italic>btuB2 att1</italic>::pNBU2_tetQ_BC14 (‘∆<italic>btuB2</italic>’ strain). Each mouse in the third group was gavaged with ~10<sup>7</sup> CFU each of the parent strain, the ∆<italic>btuG2</italic> strain, and <italic>B. thetaiotaomicron</italic> ∆<italic>tdk</italic> ∆<italic>locus1</italic> ∆<italic>locus3</italic> ∆<italic>btuG2 att1</italic>::pNBU2_tetQ_BC16_us1957_<italic>btuG2</italic> (‘∆<italic>btuG2 + btuG2</italic>’ strain). Fecal samples were collected over time and stored at −80°C before genomic DNA extraction. DNA was extracted as described previously (<xref ref-type="bibr" rid="bib13">Cullen et al., 2015</xref>). The relative abundance of each strain was determined using oligonucleotide barcode-specific primers (<xref ref-type="supplementary-material" rid="supp1">Supplementaryfile 1</xref>) in a qPCR assay as described above.</p></sec><sec id="s4-7"><title>B<sub>12</sub> riboswitch biosensor assays</title><p><italic>B. thetaiotaomicron</italic> strains were grown in triplicate anaerobically at 37 ˚C to mid-log phase (OD600 ~0.3) in minimal media supplemented with methionine and vitamin B<sub>12</sub> (0, 0.37, or 37 nM). RNA was extracted using a cell lysis buffer (10 mM Tris pH 8.0, 1 mM EDTA, 0.2 mg lysozyme, 0.5 mg proteinase K) and an RNeasy kit (Qiagen, Hilden, Germany). DNA was removed using DNA-free DNA Removal Kit (Invitrogen, Carlsbad, CA, USA), and RNA was again cleaned using an RNeasy kit (Qiagen, Hilden, Germany). cDNA was then made with SuperScript II Reverse Transcriptase (Invitrogen, Carlsbad, CA, USA) using the manufacturer’s instructions, and RNA was removed with 1 N NaOH at 65 ˚C for 30 min and neutralized with 1 N HCl. Samples were then cleaned using a PCR purification kit (Qiagen) and cDNA was quantified using a Qubit (Invitrogen, Carlsbad, CA, USA). Quantitative PCR was performed using SYBR FAST Universal Mastermix (KAPA Biosystems, Wilmington, MA, USA) and gene-specific primers (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). Samples were normalized first to 16S rRNA expression for each individual sample and replicate, and then normalized to the expression level of each strain in 0 nM B<sub>12</sub> (<xref ref-type="fig" rid="fig1">Figure 1D</xref>) or the <italic>btuG2</italic> complement strain in 0.37 nM B<sub>12</sub> (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>). A standard curve and efficiency-corrected ∆Cq method was used to determine relative fold changes (<xref ref-type="bibr" rid="bib7">Bookout et al., 2006</xref>).</p></sec><sec id="s4-8"><title>Immunoblotting</title><p>Detection of BtuG2 from <italic>B. thetaiotaomicron</italic> lysates was performed by Western blot analysis using a custom-made rabbit anti-BtuG2 polyclonal antibody (Cocalico Biologicals, Reamstown, PA, USA).</p></sec><sec id="s4-9"><title>Proteinase K assay</title><p>A <italic>B. thetaiotaomicron</italic> strain expressing an HA-epitope tagged allele of the periplasmic protein SusA (<xref ref-type="bibr" rid="bib48">Shipman et al., 1999</xref>) was grown to OD600 ~0.8 in minimal media with methionine, pelleted and washed in 1x cOmplete EDTA-free protease-inhibitor cocktail (Roche, Basel, Switzerland) before being pelleted and stored at −80 ˚C. Pellets were thawed and resuspended in PBS with proteinase K (0, 10, 50 or 100 µg/mL; AmericanBio, Natick, MA, USA), and incubated at 37 ˚C aerobically under continuous agitation (250 rpm) for 8 hr. Cells were then pelleted and washed 3 times in 1x cOmplete EDTA-free protease-inhibitor cocktail, pelleted and stored at −80 ˚C. Thawed cells were lysed using BugBuster reagent (Millipore Sigma, Burlington, MA, USA), 20 µg of clarified protein lysate was loaded onto an SDS-PAGE gel, transferred to a PVDF membrane and probed with rabbit anti-BtuG2 and rabbit anti-HA (Santa Cruz Biotechnology, Dallas, TX, USA).</p></sec><sec id="s4-10"><title>Cell fractionation</title><p><italic>B. thetaiotaomicron</italic> cultures were grown to OD600 ~0.6 in minimal media with methionine. Cells were pelleted (~3000 x g for 15 min at 4˚C) and supernatant was filtered through 0.2 µm filter and stored temporarily on ice. Pellets were resuspended in breakage buffer (50 mM Tris pH 8, 5 mM EDTA, 2 mM PMSF, 10% glycerol), lysed at 4˚C by sonication (40 Amps; 15 s ‘on’ and 30 s ‘off’; 3 min total), and clarified lysates were ultracentrifuged at 100,000 x g for 1 hr at 4˚C to separate membranes (insoluble) from cytoplasm/periplasm (soluble) fractions. Membrane fractions were resuspended in 250 µl of breakage buffer, while the cytoplasm/periplasm fraction was concentrated by centrifugal filtration (30K; Millipore Sigma, Burlington, MA, USA) to 250 µl. Membrane and cytoplasm/periplasm fractions were temporarily stored on ice. Filtered supernatant was utracentrifuged at ~100,000 x g for 1 hr at 4˚C to remove outer membrane vesicles. The soluble fraction was then concentrated by centrifugal filtration to 250 µl. 20 µl each of membrane, cytoplasm/periplasm, and supernatant fractions were loaded onto SDS-PAGE gels and analyzed by Western blot. PVDF membranes were probed with rabbit anti-BtuG2 and mouse anti-RpoB (Santa Cruz Biotechnology, Dallas, TX, USA) as a cytoplasmic control.</p></sec><sec id="s4-11"><title>Co-immunoprecipitation</title><p><italic>B. thetaiotaomicron</italic> strains were grown to OD600 ~0.6 in minimal media with methionine. Cells were pelleted, supernatant was removed, and cells were lysed with BugBuster reagent. Co-immunoprecipitation was carried out using FLAG HA Tandem Affinity Purification kit (Millipore Sigma, Burlington, MA, USA) according to the manufacturer’s instructions. Eluates were probed with rabbit anti-BtuG2 by Western blot.</p></sec><sec id="s4-12"><title><italic>Trans-</italic>complementation assays</title><p>Overnight cultures of <italic>B. thetaiotaomicron</italic> strains were grown in minimal media with methionine. Supernatant donor strains were subcultured (1:100) into 60 mL fresh minimal media with methionine and allowed to grow to OD600 ~0.6. Supernatant recipient strains were washed 3 times in minimal media without methionine or vitamin B<sub>12</sub>, subcultured to a final OD600 ~0.001 in 1 mL minimal media without methionine or vitamin B<sub>12</sub>, and incubated at 37 ˚C anaerobically for 8 – 12 hr. Supernatant donor cultures were pelleted and supernatant filtered (0.2 µm). Filtered supernatants were then ultracentrifuged at 100,000 x g for 1 hr at 4 ˚C to remove outer membrane vesicles and concentrated to &lt;2 mL by centrifugal filtration (30K; Millipore Sigma, Burlington, MA, USA). Where indicated, concentrated supernatants were supplemented with 0.37 µM vitamin B<sub>12</sub> or PBS and incubated for 20 min at room temperature aerobically on a nutator. Supernatants were then washed 4 times in 70 mL minimal media without methionine or vitamin B<sub>12</sub> by centrifugal filtration (30K). Washed, concentrated supernatants were then applied to recipient cell cultures and incubated at 37 ˚C anaerobically. CFU measurements were taken at regular intervals. For assays involving IF, recombinant human IF (Xeragenx LLC) was incubated in 0.37 µM vitamin B<sub>12</sub> or PBS for 20 min at room temperature on a nutator, and washed 4 times in 70 mL minimal media without methionine or vitamin B<sub>12</sub> via centrifugal filtration (30K). IF (± vitamin B<sub>12</sub>) was provided either alone to recipient cell cultures (e.g., <xref ref-type="fig" rid="fig5">Figure 5A</xref>) or with B<sub>12</sub>-free donor supernatants (e.g., <xref ref-type="fig" rid="fig5">Figure 5C</xref>) at a final concentration of 10 nM IF per replicate. Cultures were incubated at 37˚C anaerobically and CFU measurements were taken at regular intervals.</p></sec><sec id="s4-13"><title>Size-exclusion chromatography with multi-angle light scattering (SEC-MALS)</title><p>Recombinant BtuG2-6xHis or BtuG2-10xHis was expressed and purified from <italic>E. coli</italic> BL21 Rosetta (DE3) carrying a modified pET21 vector. Cells were grown to OD600 ~0.6 before being induced for 3 hr in 0.5 mM IPTG at 37 ˚C under constant agitation. Cell pellets were lysed using BugBuster reagent (Millipore Sigma, Burlington, MA, USA). Lysates were incubated for 1 hr at 4 ˚C with Ni-NTA agarose beads (Qiagen, Hilden, Germany) and washed with 12 – 18 mL of wash buffer (50 mM NaH<sub>2</sub>PO<sub>4</sub>, 300 mM NaCl, 20 mM imidazole pH 7.4), and eluted with 6 mL elution buffer (50 mM NaH<sub>2</sub>PO<sub>4</sub>, 300 mM NaCl, 250 mM imidazole, pH 7.4). BtuG2-6xHis or BtuG2-10xHis fractions were dialyzed overnight in 20 mM Tris pH eight before being spun through a Pierce<sup>TM</sup> strong anion exchange column (ThermoFisher Scientific, Waltham, MA, USA) according to the manufacturer’s instructions. Eluted proteins were dialyzed twice for 4–8 hr in 4 L of PBS, pH 8. Proteins were quantified by Bradford assay (Bio-Rad, Hercules, CA, USA) according to the manufacturer’s instructions. BtuG2-6xHis was incubated at a 1:1 molar ratio of cyanocobalamin to protein for 30 min at 25 ˚C and analyzed by SEC-MALS. BtuG2-10xHis was enriched for protein monomers by size exclusion chromatography and quantified using a NanoDrop spectrophotometer (ThermoFisher Scientific, Waltham, MA, USA) for use in SPR experiments (described below).</p></sec><sec id="s4-14"><title>Cyanocobalamin binding by BtuG homologs from <italic>B. thetaiotaomicron</italic>, <italic>B. vulgatus, B. uniformis</italic> and <italic>B. coprophilus</italic></title><p>pET21_NESG was used to express and purify C-terminal 6xHis-tagged versions of the BtuG homologs BVU2056, BACUNI04578 and BACCOPRO02032 as described above for BtuG2. Each BtuG homolog, or BSA or PBS as controls, was incubated at a 1:1 molar ratio of cyanocobalamin to protein for 30 min at 25 ˚C before being spun through a centrifugal filter (30K; Millipore Sigma, Burlington, MA, USA) to elute unbound cyanocobalamin. Proteins were washed 3 times with 400 µl PBS. Retained protein-cyanocobalamin complexes were resuspended in 100 µl PBS and analyzed by spectrophotometry for absorbance at 360 nm, corresponding to cyanocobalamin.</p></sec><sec id="s4-15"><title>Surface plasmon resonance (SPR)</title><p>Binding studies were performed at 25°C using a Biacore T100 optical biosensor (GE HealthCare, Biacore, Piscataway, NJ, USA). Recombinant BtuG2-10xHis was purified from <italic>E. coli</italic> BL21 Rosetta (DE3) as described above and immobilized on a NTA chip. Cyanocobalamin was injected at 0.8, 0.4, 0.2, 0.1, and 0.05 nM and the binding was monitored in single cycle kinetics in PBS (<xref ref-type="bibr" rid="bib29">Karlsson et al., 2006</xref>). Binding responses were double-referenced against non-specific binding to dextran and the NTA surface alone, and against injections of buffer alone. Binding affinity was determined by fitting the kinetics of the binding reaction to a 1:1 binding model using BioEvaluation software (GE HealthCare, Biacore, Piscataway, NJ, USA).</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We thank members of ALG’s laboratory; Michiko Taga, Kenny Mok, and Nicole Koropatkin for helpful discussions; the Northeast Structural Genomics Consortium for pET21_NESG_BT1954; Robert Doyle and Xeragenx LLC for the gift of recombinant human intrinsic factor. This work was supported by NIH grants GM118159, GM103574, the Burroughs Wellcome Fund, and the Howard Hughes Medical Institute Faculty Scholars Program to ALG, and support from the Gruber Science Fellowship Program to AGW.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Data curation, Formal analysis, Investigation, Visualization, Methodology, Writing—original draft</p></fn><fn fn-type="con" id="con2"><p>Investigation, Writing—review and editing</p></fn><fn fn-type="con" id="con3"><p>Formal analysis, Investigation, Methodology, Writing—review and editing</p></fn><fn fn-type="con" id="con4"><p>Formal analysis, Methodology</p></fn><fn fn-type="con" id="con5"><p>Investigation, Methodology</p></fn><fn fn-type="con" id="con6"><p>Conceptualization, Resources, Formal analysis, Supervision, Funding acquisition, Writing—original draft, Writing—review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols (#2017-11423) of Yale University.</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><object-id pub-id-type="doi">10.7554/eLife.37138.012</object-id><label>Supplementary file 1.</label><caption><title>(Table S1) Identified BtuB-BtuG pairs from BlastP and Phyre2 searches of BT1490, BT1954 and BT2095.</title><p>(Table S2) Amino acid sequences of 114 BtuG homologs used to create the sequence logo in <xref ref-type="fig" rid="fig2">Figure 2A</xref>. (Table S3) Bacterial strains, plasmids and oligonucleotide primers used in this study.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-37138-supp1-v1.xlsx"/></supplementary-material><supplementary-material id="transrepform"><object-id pub-id-type="doi">10.7554/eLife.37138.013</object-id><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-37138-transrepform-v1.docx"/></supplementary-material><p>All data generated or analyzed during this study are included in the manuscript and supporting files. Source data files have been provided for Figures 1A and 2A.</p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Allen</surname> <given-names>RH</given-names></name><name><surname>Stabler</surname> <given-names>SP</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Identification and quantitation of cobalamin and cobalamin analogues in human feces</article-title><source>The American Journal of Clinical Nutrition</source><volume>87</volume><fpage>1324</fpage><lpage>1335</lpage><pub-id pub-id-type="doi">10.1093/ajcn/87.5.1324</pub-id><pub-id pub-id-type="pmid">18469256</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Altschul</surname> <given-names>SF</given-names></name><name><surname>Gish</surname> <given-names>W</given-names></name><name><surname>Miller</surname> <given-names>W</given-names></name><name><surname>Myers</surname> <given-names>EW</given-names></name><name><surname>Lipman</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Basic local alignment search tool</article-title><source>Journal of Molecular Biology</source><volume>215</volume><fpage>403</fpage><lpage>410</lpage><pub-id pub-id-type="doi">10.1016/S0022-2836(05)80360-2</pub-id><pub-id pub-id-type="pmid">2231712</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arenas</surname> <given-names>FA</given-names></name><name><surname>Díaz</surname> <given-names>WA</given-names></name><name><surname>Leal</surname> <given-names>CA</given-names></name><name><surname>Pérez-Donoso</surname> <given-names>JM</given-names></name><name><surname>Imlay</surname> <given-names>JA</given-names></name><name><surname>Vásquez</surname> <given-names>CC</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The Escherichia coli btuE gene, encodes a glutathione peroxidase that is induced under oxidative stress conditions</article-title><source>Biochemical and Biophysical Research Communications</source><volume>398</volume><fpage>690</fpage><lpage>694</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2010.07.002</pub-id><pub-id pub-id-type="pmid">20621065</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barnes</surname> <given-names>RH</given-names></name></person-group><year iso-8601-date="1967">1967</year><article-title>Contributions of the intestinal microflora to the nutrition of the host</article-title><source>Vitamins &amp; Hormones</source><volume>24</volume><fpage>115</fpage><lpage>171</lpage></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bassford</surname> <given-names>PJ</given-names></name><name><surname>Bradbeer</surname> <given-names>C</given-names></name><name><surname>Kadner</surname> <given-names>RJ</given-names></name><name><surname>Schnaitman</surname> <given-names>CA</given-names></name></person-group><year iso-8601-date="1976">1976</year><article-title>Transport of vitamin B12 in tonB mutants of Escherichia coli</article-title><source>Journal of Bacteriology</source><volume>128</volume><fpage>242</fpage><lpage>247</lpage><pub-id pub-id-type="pmid">135755</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bassford</surname> <given-names>PJ</given-names></name><name><surname>Kadner</surname> <given-names>RJ</given-names></name></person-group><year iso-8601-date="1977">1977</year><article-title>Genetic analysis of components involved in vitamin B12 uptake in Escherichia coli</article-title><source>Journal of Bacteriology</source><volume>132</volume><fpage>796</fpage><lpage>805</lpage><pub-id pub-id-type="pmid">336607</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bookout</surname> <given-names>AL</given-names></name><name><surname>Cummins</surname> <given-names>CL</given-names></name><name><surname>Mangelsdorf</surname> <given-names>DJ</given-names></name><name><surname>Pesola</surname> <given-names>JM</given-names></name><name><surname>Kramer</surname> <given-names>MF</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>High-Throughput Real-Time quantitative reverse transcription PCR</article-title><source>Current Protocols in Molecular Biology</source><volume>73</volume><fpage>15.8.1</fpage><lpage>15.815</lpage><pub-id pub-id-type="doi">10.1002/0471142727.mb1508s73</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brada</surname> <given-names>N</given-names></name><name><surname>Gordon</surname> <given-names>MM</given-names></name><name><surname>Wen</surname> <given-names>J</given-names></name><name><surname>Alpers</surname> <given-names>DH</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Transfer of cobalamin from intrinsic factor to transcobalamin II</article-title><source>The Journal of Nutritional Biochemistry</source><volume>12</volume><fpage>200</fpage><lpage>206</lpage><pub-id pub-id-type="doi">10.1016/S0955-2863(00)00129-7</pub-id><pub-id pub-id-type="pmid">11287214</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cadieux</surname> <given-names>N</given-names></name><name><surname>Bradbeer</surname> <given-names>C</given-names></name><name><surname>Reeger-Schneider</surname> <given-names>E</given-names></name><name><surname>Köster</surname> <given-names>W</given-names></name><name><surname>Mohanty</surname> <given-names>AK</given-names></name><name><surname>Wiener</surname> <given-names>MC</given-names></name><name><surname>Kadner</surname> <given-names>RJ</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Identification of the periplasmic cobalamin-binding protein BtuF of Escherichia coli</article-title><source>Journal of Bacteriology</source><volume>184</volume><fpage>706</fpage><lpage>717</lpage><pub-id pub-id-type="doi">10.1128/JB.184.3.706-717.2002</pub-id><pub-id pub-id-type="pmid">11790740</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Collaborative Computational Project, Number 4</collab></person-group><year iso-8601-date="1994">1994</year><article-title>The CCP4 suite: programs for protein crystallography</article-title><source>Acta Crystallographica Section D Biological Crystallography</source><volume>50</volume><fpage>760</fpage><lpage>763</lpage><pub-id pub-id-type="doi">10.1107/S0907444994003112</pub-id><pub-id pub-id-type="pmid">15299374</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corzo</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Time, the forgotten dimension of ligand binding teaching</article-title><source>Biochemistry and Molecular Biology Education</source><volume>34</volume><fpage>413</fpage><lpage>416</lpage><pub-id pub-id-type="doi">10.1002/bmb.2006.494034062678</pub-id><pub-id pub-id-type="pmid">21638733</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crooks</surname> <given-names>GE</given-names></name><name><surname>Hon</surname> <given-names>G</given-names></name><name><surname>Chandonia</surname> <given-names>JM</given-names></name><name><surname>Brenner</surname> <given-names>SE</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>WebLogo: a sequence logo generator</article-title><source>Genome Research</source><volume>14</volume><fpage>1188</fpage><lpage>1190</lpage><pub-id pub-id-type="doi">10.1101/gr.849004</pub-id><pub-id pub-id-type="pmid">15173120</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cullen</surname> <given-names>TW</given-names></name><name><surname>Schofield</surname> <given-names>WB</given-names></name><name><surname>Barry</surname> <given-names>NA</given-names></name><name><surname>Putnam</surname> <given-names>EE</given-names></name><name><surname>Rundell</surname> <given-names>EA</given-names></name><name><surname>Trent</surname> <given-names>MS</given-names></name><name><surname>Degnan</surname> <given-names>PH</given-names></name><name><surname>Booth</surname> <given-names>CJ</given-names></name><name><surname>Yu</surname> <given-names>H</given-names></name><name><surname>Goodman</surname> <given-names>AL</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Antimicrobial peptide resistance mediates resilience of prominent gut commensals during inflammation</article-title><source>Science</source><volume>347</volume><fpage>170</fpage><lpage>175</lpage><pub-id pub-id-type="doi">10.1126/science.1260580</pub-id><pub-id pub-id-type="pmid">25574022</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Veaux</surname> <given-names>LC</given-names></name><name><surname>Clevenson</surname> <given-names>DS</given-names></name><name><surname>Bradbeer</surname> <given-names>C</given-names></name><name><surname>Kadner</surname> <given-names>RJ</given-names></name></person-group><year iso-8601-date="1986">1986</year><article-title>Identification of the btuCED polypeptides and evidence for their role in vitamin B12 transport in Escherichia coli</article-title><source>Journal of Bacteriology</source><volume>167</volume><fpage>920</fpage><lpage>927</lpage><pub-id pub-id-type="doi">10.1128/jb.167.3.920-927.1986</pub-id><pub-id pub-id-type="pmid">3528128</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Degnan</surname> <given-names>PH</given-names></name><name><surname>Barry</surname> <given-names>NA</given-names></name><name><surname>Mok</surname> <given-names>KC</given-names></name><name><surname>Taga</surname> <given-names>ME</given-names></name><name><surname>Goodman</surname> <given-names>AL</given-names></name></person-group><year iso-8601-date="2014">2014a</year><article-title>Human gut microbes use multiple transporters to distinguish vitamin B₁₂ analogs and compete in the gut</article-title><source>Cell Host &amp; Microbe</source><volume>15</volume><fpage>47</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2013.12.007</pub-id><pub-id pub-id-type="pmid">24439897</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Degnan</surname> <given-names>PH</given-names></name><name><surname>Taga</surname> <given-names>ME</given-names></name><name><surname>Goodman</surname> <given-names>AL</given-names></name></person-group><year iso-8601-date="2014">2014b</year><article-title>Vitamin B12 as a modulator of gut microbial ecology</article-title><source>Cell Metabolism</source><volume>20</volume><fpage>769</fpage><lpage>778</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2014.10.002</pub-id><pub-id pub-id-type="pmid">25440056</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Girolamo</surname> <given-names>PM</given-names></name><name><surname>Kadner</surname> <given-names>RJ</given-names></name><name><surname>Bradbeer</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="1971">1971</year><article-title>Isolation of vitamin B 12 transport mutants of Escherichia coli</article-title><source>Journal of Bacteriology</source><volume>106</volume><fpage>751</fpage><lpage>757</lpage><pub-id pub-id-type="pmid">4326741</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dolinsky</surname> <given-names>TJ</given-names></name><name><surname>Nielsen</surname> <given-names>JE</given-names></name><name><surname>McCammon</surname> <given-names>JA</given-names></name><name><surname>Baker</surname> <given-names>NA</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations</article-title><source>Nucleic Acids Research</source><volume>32</volume><fpage>W665</fpage><lpage>W667</lpage><pub-id pub-id-type="doi">10.1093/nar/gkh381</pub-id><pub-id pub-id-type="pmid">15215472</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fedosov</surname> <given-names>SN</given-names></name><name><surname>Fedosova</surname> <given-names>NU</given-names></name><name><surname>Berglund</surname> <given-names>L</given-names></name><name><surname>Moestrup</surname> <given-names>SK</given-names></name><name><surname>Nexø</surname> <given-names>E</given-names></name><name><surname>Petersen</surname> <given-names>TE</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Composite organization of the cobalamin binding and cubilin recognition sites of intrinsic factor</article-title><source>Biochemistry</source><volume>44</volume><fpage>3604</fpage><lpage>3614</lpage><pub-id pub-id-type="doi">10.1021/bi047936v</pub-id><pub-id pub-id-type="pmid">15736970</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fedosov</surname> <given-names>SN</given-names></name><name><surname>Grissom</surname> <given-names>CB</given-names></name><name><surname>Fedosova</surname> <given-names>NU</given-names></name><name><surname>Moestrup</surname> <given-names>SK</given-names></name><name><surname>Nexø</surname> <given-names>E</given-names></name><name><surname>Petersen</surname> <given-names>TE</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Application of a fluorescent cobalamin analogue for analysis of the binding kinetics. A study employing recombinant human transcobalamin and intrinsic factor</article-title><source>The FEBS journal</source><volume>273</volume><fpage>4742</fpage><lpage>4753</lpage><pub-id pub-id-type="doi">10.1111/j.1742-4658.2006.05478.x</pub-id><pub-id pub-id-type="pmid">16984395</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fowler</surname> <given-names>CC</given-names></name><name><surname>Brown</surname> <given-names>ED</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Using a riboswitch sensor to examine coenzyme B(12) metabolism and transport in E. coli</article-title><source>Chemistry &amp; Biology</source><volume>17</volume><fpage>756</fpage><lpage>765</lpage><pub-id pub-id-type="doi">10.1016/j.chembiol.2010.05.025</pub-id><pub-id pub-id-type="pmid">20659688</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Getzoff</surname> <given-names>ED</given-names></name><name><surname>Tainer</surname> <given-names>JA</given-names></name><name><surname>Weiner</surname> <given-names>PK</given-names></name><name><surname>Kollman</surname> <given-names>PA</given-names></name><name><surname>Richardson</surname> <given-names>JS</given-names></name><name><surname>Richardson</surname> <given-names>DC</given-names></name></person-group><year iso-8601-date="1983">1983</year><article-title>Electrostatic recognition between superoxide and copper, zinc superoxide dismutase</article-title><source>Nature</source><volume>306</volume><fpage>287</fpage><lpage>290</lpage><pub-id pub-id-type="doi">10.1038/306287a0</pub-id><pub-id pub-id-type="pmid">6646211</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giannella</surname> <given-names>RA</given-names></name><name><surname>Broitman</surname> <given-names>SA</given-names></name><name><surname>Zamcheck</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="1971">1971</year><article-title>Vitamin B12 uptake by intestinal microorganisms: mechanism and relevance to syndromes of intestinal bacterial overgrowth</article-title><source>Journal of Clinical Investigation</source><volume>50</volume><fpage>1100</fpage><lpage>1107</lpage><pub-id pub-id-type="doi">10.1172/JCI106581</pub-id><pub-id pub-id-type="pmid">4994753</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giannella</surname> <given-names>RA</given-names></name><name><surname>Broitman</surname> <given-names>SA</given-names></name><name><surname>Zamcheck</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="1972">1972</year><article-title>Competition between bacteria and intrinsic factor for vitamin B 12 : implications for vitamin B 12 malabsorption in intestinal bacterial overgrowth</article-title><source>Gastroenterology</source><volume>62</volume><fpage>255</fpage><lpage>260</lpage><pub-id pub-id-type="pmid">4629318</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glenwright</surname> <given-names>AJ</given-names></name><name><surname>Pothula</surname> <given-names>KR</given-names></name><name><surname>Bhamidimarri</surname> <given-names>SP</given-names></name><name><surname>Chorev</surname> <given-names>DS</given-names></name><name><surname>Baslé</surname> <given-names>A</given-names></name><name><surname>Firbank</surname> <given-names>SJ</given-names></name><name><surname>Zheng</surname> <given-names>H</given-names></name><name><surname>Robinson</surname> <given-names>CV</given-names></name><name><surname>Winterhalter</surname> <given-names>M</given-names></name><name><surname>Kleinekathöfer</surname> <given-names>U</given-names></name><name><surname>Bolam</surname> <given-names>DN</given-names></name><name><surname>van den Berg</surname> <given-names>B</given-names></name><name><surname>David</surname> <given-names>N</given-names></name><name><surname>Berg</surname> <given-names>Bvanden</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Structural basis for nutrient acquisition by dominant members of the human gut microbiota</article-title><source>Nature</source><volume>541</volume><fpage>407</fpage><lpage>411</lpage><pub-id pub-id-type="doi">10.1038/nature20828</pub-id><pub-id pub-id-type="pmid">28077872</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goodman</surname> <given-names>AL</given-names></name><name><surname>McNulty</surname> <given-names>NP</given-names></name><name><surname>Zhao</surname> <given-names>Y</given-names></name><name><surname>Leip</surname> <given-names>D</given-names></name><name><surname>Mitra</surname> <given-names>RD</given-names></name><name><surname>Lozupone</surname> <given-names>CA</given-names></name><name><surname>Knight</surname> <given-names>R</given-names></name><name><surname>Gordon</surname> <given-names>JI</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Identifying genetic determinants needed to establish a human gut symbiont in its habitat</article-title><source>Cell Host &amp; Microbe</source><volume>6</volume><fpage>279</fpage><lpage>289</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2009.08.003</pub-id><pub-id pub-id-type="pmid">19748469</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inouye</surname> <given-names>S</given-names></name><name><surname>Franceschini</surname> <given-names>T</given-names></name><name><surname>Sato</surname> <given-names>M</given-names></name><name><surname>Itakura</surname> <given-names>K</given-names></name><name><surname>Inouye</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="1983">1983</year><article-title>Prolipoprotein signal peptidase of Escherichia coli requires a cysteine residue at the cleavage site</article-title><source>The EMBO Journal</source><volume>2</volume><fpage>87</fpage><lpage>91</lpage><pub-id pub-id-type="pmid">11894915</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jing</surname> <given-names>H</given-names></name><name><surname>Takagi</surname> <given-names>J</given-names></name><name><surname>Liu</surname> <given-names>JH</given-names></name><name><surname>Lindgren</surname> <given-names>S</given-names></name><name><surname>Zhang</surname> <given-names>RG</given-names></name><name><surname>Joachimiak</surname> <given-names>A</given-names></name><name><surname>Wang</surname> <given-names>JH</given-names></name><name><surname>Springer</surname> <given-names>TA</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Archaeal surface layer proteins contain beta propeller, PKD, and beta helix domains and are related to metazoan cell surface proteins</article-title><source>Structure</source><volume>10</volume><fpage>1453</fpage><lpage>1464</lpage><pub-id pub-id-type="doi">10.1016/S0969-2126(02)00840-7</pub-id><pub-id pub-id-type="pmid">12377130</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karlsson</surname> <given-names>R</given-names></name><name><surname>Katsamba</surname> <given-names>PS</given-names></name><name><surname>Nordin</surname> <given-names>H</given-names></name><name><surname>Pol</surname> <given-names>E</given-names></name><name><surname>Myszka</surname> <given-names>DG</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Analyzing a kinetic titration series using affinity biosensors</article-title><source>Analytical Biochemistry</source><volume>349</volume><fpage>136</fpage><lpage>147</lpage><pub-id pub-id-type="doi">10.1016/j.ab.2005.09.034</pub-id><pub-id pub-id-type="pmid">16337141</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katoh</surname> <given-names>K</given-names></name><name><surname>Misawa</surname> <given-names>K</given-names></name><name><surname>Kuma</surname> <given-names>K</given-names></name><name><surname>Miyata</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform</article-title><source>Nucleic Acids Research</source><volume>30</volume><fpage>3059</fpage><lpage>3066</lpage><pub-id pub-id-type="doi">10.1093/nar/gkf436</pub-id><pub-id pub-id-type="pmid">12136088</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelley</surname> <given-names>LA</given-names></name><name><surname>Sternberg</surname> <given-names>MJ</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Protein structure prediction on the web: a case study using the phyre server</article-title><source>Nature Protocols</source><volume>4</volume><fpage>363</fpage><lpage>371</lpage><pub-id pub-id-type="doi">10.1038/nprot.2009.2</pub-id><pub-id pub-id-type="pmid">19247286</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koropatkin</surname> <given-names>NM</given-names></name><name><surname>Cameron</surname> <given-names>EA</given-names></name><name><surname>Martens</surname> <given-names>EC</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>How glycan metabolism shapes the human gut microbiota</article-title><source>Nature Reviews Microbiology</source><volume>10</volume><fpage>323</fpage><lpage>335</lpage><pub-id pub-id-type="doi">10.1038/nrmicro2746</pub-id><pub-id pub-id-type="pmid">22491358</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larkin</surname> <given-names>MA</given-names></name><name><surname>Blackshields</surname> <given-names>G</given-names></name><name><surname>Brown</surname> <given-names>NP</given-names></name><name><surname>Chenna</surname> <given-names>R</given-names></name><name><surname>McGettigan</surname> <given-names>PA</given-names></name><name><surname>McWilliam</surname> <given-names>H</given-names></name><name><surname>Valentin</surname> <given-names>F</given-names></name><name><surname>Wallace</surname> <given-names>IM</given-names></name><name><surname>Wilm</surname> <given-names>A</given-names></name><name><surname>Lopez</surname> <given-names>R</given-names></name><name><surname>Thompson</surname> <given-names>JD</given-names></name><name><surname>Gibson</surname> <given-names>TJ</given-names></name><name><surname>Higgins</surname> <given-names>DG</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Clustal W and clustal X version 2.0</article-title><source>Bioinformatics</source><volume>23</volume><fpage>2947</fpage><lpage>2948</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btm404</pub-id><pub-id pub-id-type="pmid">17846036</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lauber</surname> <given-names>F</given-names></name><name><surname>Cornelis</surname> <given-names>GR</given-names></name><name><surname>Renzi</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Identification of a new lipoprotein export signal in Gram-Negative Bacteria</article-title><source>mBio</source><volume>7</volume><elocation-id>16</elocation-id><pub-id pub-id-type="doi">10.1128/mBio.01232-16</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname> <given-names>GA</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>A WWW service system for automatic comparison of protein structures</article-title><source>Protein Data Bank Quarterly Newsletter</source><volume>78</volume><fpage>10</fpage><lpage>11</lpage></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martens</surname> <given-names>EC</given-names></name><name><surname>Chiang</surname> <given-names>HC</given-names></name><name><surname>Gordon</surname> <given-names>JI</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Mucosal glycan foraging enhances fitness and transmission of a saccharolytic human gut bacterial symbiont</article-title><source>Cell Host &amp; Microbe</source><volume>4</volume><fpage>447</fpage><lpage>457</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2008.09.007</pub-id><pub-id pub-id-type="pmid">18996345</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCaddon</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Vitamin B12 in neurology and ageing; clinical and genetic aspects</article-title><source>Biochimie</source><volume>95</volume><fpage>1066</fpage><lpage>1076</lpage><pub-id pub-id-type="doi">10.1016/j.biochi.2012.11.017</pub-id><pub-id pub-id-type="pmid">23228515</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname> <given-names>E</given-names></name><name><surname>Mander</surname> <given-names>A</given-names></name><name><surname>Ames</surname> <given-names>D</given-names></name><name><surname>Carne</surname> <given-names>R</given-names></name><name><surname>Sanders</surname> <given-names>K</given-names></name><name><surname>Watters</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Cognitive impairment and vitamin B12: a review</article-title><source>International Psychogeriatrics</source><volume>24</volume><fpage>541</fpage><lpage>556</lpage><pub-id pub-id-type="doi">10.1017/S1041610211002511</pub-id><pub-id pub-id-type="pmid">22221769</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nielsen</surname> <given-names>MJ</given-names></name><name><surname>Rasmussen</surname> <given-names>MR</given-names></name><name><surname>Andersen</surname> <given-names>CB</given-names></name><name><surname>Nexø</surname> <given-names>E</given-names></name><name><surname>Moestrup</surname> <given-names>SK</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Vitamin B12 transport from food to the body's cells--a sophisticated, multistep pathway</article-title><source>Nature Reviews Gastroenterology &amp; Hepatology</source><volume>9</volume><fpage>345</fpage><lpage>354</lpage><pub-id pub-id-type="doi">10.1038/nrgastro.2012.76</pub-id><pub-id pub-id-type="pmid">22547309</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Obeid</surname> <given-names>R</given-names></name><name><surname>Fedosov</surname> <given-names>SN</given-names></name><name><surname>Nexo</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Cobalamin coenzyme forms are not likely to be superior to cyano- and hydroxyl-cobalamin in prevention or treatment of cobalamin deficiency</article-title><source>Molecular Nutrition &amp; Food Research</source><volume>59</volume><fpage>1364</fpage><lpage>1372</lpage><pub-id pub-id-type="doi">10.1002/mnfr.201500019</pub-id><pub-id pub-id-type="pmid">25820384</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pettersen</surname> <given-names>EF</given-names></name><name><surname>Goddard</surname> <given-names>TD</given-names></name><name><surname>Huang</surname> <given-names>CC</given-names></name><name><surname>Couch</surname> <given-names>GS</given-names></name><name><surname>Greenblatt</surname> <given-names>DM</given-names></name><name><surname>Meng</surname> <given-names>EC</given-names></name><name><surname>Ferrin</surname> <given-names>TE</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>UCSF Chimera--a visualization system for exploratory research and analysis</article-title><source>Journal of Computational Chemistry</source><volume>25</volume><fpage>1605</fpage><lpage>1612</lpage><pub-id pub-id-type="doi">10.1002/jcc.20084</pub-id><pub-id pub-id-type="pmid">15264254</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ripoll</surname> <given-names>DR</given-names></name><name><surname>Faerman</surname> <given-names>CH</given-names></name><name><surname>Axelsen</surname> <given-names>PH</given-names></name><name><surname>Silman</surname> <given-names>I</given-names></name><name><surname>Sussman</surname> <given-names>JL</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>An electrostatic mechanism for substrate guidance down the aromatic gorge of acetylcholinesterase</article-title><source>PNAS</source><volume>90</volume><fpage>5128</fpage><lpage>5132</lpage><pub-id pub-id-type="doi">10.1073/pnas.90.11.5128</pub-id><pub-id pub-id-type="pmid">8506359</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roth</surname> <given-names>JR</given-names></name><name><surname>Lawrence</surname> <given-names>JG</given-names></name><name><surname>Rubenfield</surname> <given-names>M</given-names></name><name><surname>Kieffer-Higgins</surname> <given-names>S</given-names></name><name><surname>Church</surname> <given-names>GM</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Characterization of the cobalamin (vitamin B12) biosynthetic genes of Salmonella typhimurium</article-title><source>Journal of Bacteriology</source><volume>175</volume><fpage>3303</fpage><lpage>3316</lpage><pub-id pub-id-type="doi">10.1128/jb.175.11.3303-3316.1993</pub-id><pub-id pub-id-type="pmid">8501034</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scheithauer</surname> <given-names>TP</given-names></name><name><surname>Dallinga-Thie</surname> <given-names>GM</given-names></name><name><surname>de Vos</surname> <given-names>WM</given-names></name><name><surname>Nieuwdorp</surname> <given-names>M</given-names></name><name><surname>van Raalte</surname> <given-names>DH</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Causality of small and large intestinal microbiota in weight regulation and insulin resistance</article-title><source>Molecular Metabolism</source><volume>5</volume><fpage>759</fpage><lpage>770</lpage><pub-id pub-id-type="doi">10.1016/j.molmet.2016.06.002</pub-id><pub-id pub-id-type="pmid">27617199</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schjönsby</surname> <given-names>H</given-names></name><name><surname>Drasar</surname> <given-names>BS</given-names></name><name><surname>Tabaqchali</surname> <given-names>S</given-names></name><name><surname>Booth</surname> <given-names>CC</given-names></name></person-group><year iso-8601-date="1973">1973</year><article-title>Uptake of vitamin B 12 by intestinal bacteria in the stagnant loop syndrome</article-title><source>Scandinavian Journal of Gastroenterology</source><volume>8</volume><fpage>41</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">4633220</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schjönsby</surname> <given-names>H</given-names></name><name><surname>Halvorsen</surname> <given-names>JF</given-names></name><name><surname>Hofstad</surname> <given-names>T</given-names></name><name><surname>Hovdenak</surname> <given-names>N</given-names></name></person-group><year iso-8601-date="1977">1977</year><article-title>Stagnant loop syndrome in patients with continent ileostomy (intra-abdominal ileal reservoir)</article-title><source>Gut</source><volume>18</volume><fpage>795</fpage><lpage>799</lpage><pub-id pub-id-type="doi">10.1136/gut.18.10.795</pub-id><pub-id pub-id-type="pmid">590837</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname> <given-names>TD</given-names></name><name><surname>Stephens</surname> <given-names>RM</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Sequence logos: a new way to display consensus sequences</article-title><source>Nucleic Acids Research</source><volume>18</volume><fpage>6097</fpage><lpage>6100</lpage><pub-id pub-id-type="doi">10.1093/nar/18.20.6097</pub-id><pub-id pub-id-type="pmid">2172928</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shipman</surname> <given-names>JA</given-names></name><name><surname>Cho</surname> <given-names>KH</given-names></name><name><surname>Siegel</surname> <given-names>HA</given-names></name><name><surname>Salyers</surname> <given-names>AA</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Physiological characterization of SusG, an outer membrane protein essential for starch utilization by Bacteroides thetaiotaomicron</article-title><source>Journal of Bacteriology</source><volume>181</volume><fpage>7206</fpage><lpage>7211</lpage><pub-id pub-id-type="pmid">10572122</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shipman</surname> <given-names>JA</given-names></name><name><surname>Berleman</surname> <given-names>JE</given-names></name><name><surname>Salyers</surname> <given-names>AA</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Characterization of four outer membrane proteins involved in binding starch to the cell surface of Bacteroides thetaiotaomicron</article-title><source>Journal of Bacteriology</source><volume>182</volume><fpage>5365</fpage><lpage>5372</lpage><pub-id pub-id-type="doi">10.1128/JB.182.19.5365-5372.2000</pub-id><pub-id pub-id-type="pmid">10986238</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sonnenburg</surname> <given-names>JL</given-names></name><name><surname>Xu</surname> <given-names>J</given-names></name><name><surname>Leip</surname> <given-names>DD</given-names></name><name><surname>Chen</surname> <given-names>CH</given-names></name><name><surname>Westover</surname> <given-names>BP</given-names></name><name><surname>Weatherford</surname> <given-names>J</given-names></name><name><surname>Buhler</surname> <given-names>JD</given-names></name><name><surname>Gordon</surname> <given-names>JI</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Glycan foraging in vivo by an intestine-adapted bacterial symbiont</article-title><source>Science</source><volume>307</volume><fpage>1955</fpage><lpage>1959</lpage><pub-id pub-id-type="doi">10.1126/science.1109051</pub-id><pub-id pub-id-type="pmid">15790854</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sonnenburg</surname> <given-names>ED</given-names></name><name><surname>Sonnenburg</surname> <given-names>JL</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Gut microbes take their vitamins</article-title><source>Cell Host &amp; Microbe</source><volume>15</volume><fpage>5</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1016/j.chom.2013.12.011</pub-id><pub-id pub-id-type="pmid">24439893</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname> <given-names>RC</given-names></name><name><surname>Truong</surname> <given-names>TN</given-names></name><name><surname>McCammon</surname> <given-names>JA</given-names></name><name><surname>Sussman</surname> <given-names>JL</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Acetylcholinesterase: electrostatic steering increases the rate of ligand binding</article-title><source>Biochemistry</source><volume>32</volume><fpage>401</fpage><lpage>403</lpage><pub-id pub-id-type="doi">10.1021/bi00053a003</pub-id><pub-id pub-id-type="pmid">8422348</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Truett</surname> <given-names>GE</given-names></name><name><surname>Heeger</surname> <given-names>P</given-names></name><name><surname>Mynatt</surname> <given-names>RL</given-names></name><name><surname>Truett</surname> <given-names>AA</given-names></name><name><surname>Walker</surname> <given-names>JA</given-names></name><name><surname>Warman</surname> <given-names>ML</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Preparation of PCR-quality mouse genomic DNA with hot sodium hydroxide and tris (HotSHOT)</article-title><source>BioTechniques</source><volume>29</volume><fpage>52</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.2144/00291bm09</pub-id><pub-id pub-id-type="pmid">10907076</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>von Heijne</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="1989">1989</year><article-title>The structure of signal peptides from bacterial lipoproteins</article-title><source>&quot;Protein Engineering, Design and Selection&quot;</source><volume>2</volume><fpage>531</fpage><lpage>534</lpage><pub-id pub-id-type="doi">10.1093/protein/2.7.531</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whitman</surname> <given-names>WB</given-names></name><name><surname>Coleman</surname> <given-names>DC</given-names></name><name><surname>Wiebe</surname> <given-names>WJ</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Prokaryotes: the unseen majority</article-title><source>PNAS</source><volume>95</volume><fpage>6578</fpage><lpage>6583</lpage><pub-id pub-id-type="doi">10.1073/pnas.95.12.6578</pub-id><pub-id pub-id-type="pmid">9618454</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Young</surname> <given-names>DB</given-names></name><name><surname>Comas</surname> <given-names>I</given-names></name><name><surname>de Carvalho</surname> <given-names>LP</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Phylogenetic analysis of vitamin B12-related metabolism in Mycobacterium tuberculosis</article-title><source>Frontiers in Molecular Biosciences</source><volume>2</volume><elocation-id>6</elocation-id><pub-id pub-id-type="doi">10.3389/fmolb.2015.00006</pub-id><pub-id pub-id-type="pmid">25988174</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="SA1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.37138.015</article-id><title-group><article-title>Decision letter</article-title></title-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.</p></boxed-text><p>Thank you for submitting your article &quot;Human Gut Bacteria Capture Vitamin B<sub>12</sub> from their Environment and Host via Cell Surface-Exposed Lipoproteins&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Wendy Garrett as the Senior Editor. The following individual involved in review of your submission has agreed to reveal his identity: Jan Peter van Pijkeren (Reviewer #3).</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>Summary:</p><p>The reviewers agreed that this paper represents a very interesting, well-designed, and well-conducted study of vitamin B<sub>12</sub> uptake in an important gut commensal. The authors center their study on BtuB, an outer membrane lipoprotein from <italic>Bacteroides thetaiotaomicron</italic>. They perform a series of careful biochemical analyses that reveal that BtuG is essential for B<sub>12</sub> transport into the cell. They further show that BtuG is key for the in vivo fitness of <italic>B. thetaiotaomicron</italic>. A major claim is that BtuG is involved in &quot;vitamin piracy&quot; by competing with human intrinsic factor for vitamin B<sub>12</sub> binding.</p><p>Overall, the study presents novel insight into how gut commensals obtain essential vitamins in the complex gastrointestinal environment. The study is well-conducted, well-written, and the data on BtuG function in <italic>B. thetaiotaomicron</italic> vitamin B<sub>12</sub> uptake is convincing. The reviewers felt that overall, the work provides valuable new insight into nutrient acquisition strategies of intestinal commensal bacteria. However, as detailed below, there were concerns about the basis for the vitamin piracy claim that need to be addressed in a revised manuscript.</p><p>Essential revisions:</p><p>1) A major claim of this study is that BtuG is involved in &quot;vitamin piracy&quot; by capturing vitamin B<sub>12</sub> from human intrinsic factor. The experiments supporting this claim were all conducted in vitro. In vivo experiments showing that the wild-type bacteria capture B<sub>12</sub> from the host, while the mutant does not, would greatly strengthen this central claim of the paper. However, the reviewers recognized that such an in vivo experiment could pose some difficult technical challenges and might not be doable in a restricted time-frame. In that case, we suggest that the title and Abstract be revised with less emphasis on the idea of B<sub>12</sub> capture from the host. In addition, the discussion would need to be improved by discussing alternative possibilities as suggested in point 3 below.</p><p>2) <italic>∆btuG2</italic> and <italic>∆btuB2</italic> are outcompeted by the parent strain in a germ-free mouse (Figure 1E, F). Since this is the only in vivo data demonstrating the role of these proteins in intestinal fitness, it is important that – at least for one of these proteins – that its function is complemented to conclusively demonstrate that the reduction in fitness is attributable to deletion of <italic>btuG2</italic> or <italic>btuB2</italic>.</p><p>3) Vitamin B<sub>12</sub> availability in the colon is an essential underpinning of the vitamin piracy claim. In the discussion amongst the reviewers, there were questions raised about whether vitamin B<sub>12</sub> is likely to be freely available in the colon given that it is typically absorbed in the small intestine. This may also be a point of confusion for some readers, and thus we suggest some further discussion and/or clarification of this point. The following points were raised as possible avenues for clarification:</p><p>a) A reviewer pointed out that there can be small intestinal populations of <italic>B. theta</italic> (albeit at lower density) – is it possible that the piracy is therefore occurring primarily among these small intestinal populations rather than those present in the colon?</p><p>b) Is it possible that BtuG could be a factor that has evolved to allow successful competition with other microbes, rather than with the host? This would plausibly constitute enough selection pressure for the high affinity of the protein for B<sub>12</sub> to emerge.</p><p>c) Can <italic>B. thetaiotaomicron</italic> utilize pseudovitamin B<sub>12</sub>, and – if so – how does the utilization (i.e. growth) compare to vitamin B<sub>12</sub>? Pseudovitamin B<sub>12</sub> is produced by select gut bacteria (i.e. <italic>Lactobacillus reuteri</italic> and <italic>Eubacterium hallii</italic>), food-associated microbes (i.e. <italic>Arthrospira platensis</italic>), or used as a food additive. Although pseudovitamin B<sub>12</sub> is another source of B<sub>12</sub>, it cannot be absorbed in the human GI tract (it does bind IF). If <italic>B. thetaiotaomicron</italic> can utilize pseudovitamin B<sub>12</sub> more efficiently than B<sub>12</sub>, then <italic>B. thetaiotaomicron</italic> would be beneficial for human health rather than detrimental, as the authors speculate in their Discussion (third paragraph).</p></body></sub-article><sub-article article-type="reply" id="SA2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.37138.016</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential Revisions:</p><p>1) A major claim of this study is that BtuG is involved in &quot;vitamin piracy&quot; by capturing vitamin B<sub>12</sub> from human intrinsic factor. The experiments supporting this claim were all conducted in vitro. In vivo experiments showing that the wild-type bacteria capture B<sub>12</sub> from the host, while the mutant does not, would greatly strengthen this central claim of the paper. However, the reviewers recognized that such an in vivo experiment could pose some difficult technical challenges and might not be doable in a restricted time-frame. In that case, we suggest that the title and Abstract be revised with less emphasis on the idea of B<sub>12</sub> capture from the host. In addition, the discussion would need to be improved by discussing alternative possibilities as suggested in point 3 below.</p></disp-quote><p>We agree with this suggestion and have revised the title, Abstract, and Discussion accordingly.</p><disp-quote content-type="editor-comment"><p>2) ∆btuG2 and ∆btuB2 are outcompeted by the parent strain in a germ-free mouse (Figure 1E, F). Since this is the only in vivo data demonstrating the role of these proteins in intestinal fitness, it is important that – at least for one of these proteins – that its function is complemented to conclusively demonstrate that the reduction in fitness is attributable to deletion of btuG2 or btuB2.</p></disp-quote><p>It has been previously shown that the competitive fitness defect of the <italic>btuB2</italic> mutant in vivo can be complemented by expression of the gene in single copy from a heterologous chromosomal locus (Degnan et al., 2014, Figure 4A, B). We have added this information to the paper.</p><p>In response to this comment, we conducted new experiments measuring the fitness of wildtype, <italic>∆btuG2</italic>, and complemented strains in gnotobiotic mice. These new data have been added to the paper as Figure 1—figure supplement 1.</p><disp-quote content-type="editor-comment"><p>3) Vitamin B<sub>12</sub> availability in the colon is an essential underpinning of the vitamin piracy claim. In the discussion amongst the reviewers, there were questions raised about whether vitamin B<sub>12</sub> is likely to be freely available in the colon given that it is typically absorbed in the small intestine. This may also be a point of confusion for some readers, and thus we suggest some further discussion and/or clarification of this point. The following points were raised as possible avenues for clarification:</p><p>a) A reviewer pointed out that there can be small intestinal populations of B. theta (albeit at lower density) – is it possible that the piracy is therefore occurring primarily among these small intestinal populations rather than those present in the colon?</p></disp-quote><p>We agree with the reviewer and have suggested this possibility (see subsection “<italic>B. thetaiotaomicron</italic> can use BtuG2 to acquire cyanocobalamin from human intrinsic factor” and Discussion, paragraph six).</p><disp-quote content-type="editor-comment"><p>b) Is it possible that BtuG could be a factor that has evolved to allow successful competition with other microbes, rather than with the host? This would plausibly constitute enough selection pressure for the high affinity of the protein for B<sub>12</sub> to emerge.</p></disp-quote><p>Yes, we think this is the most likely explanation for our observations (see Discussion, paragraph two).</p><disp-quote content-type="editor-comment"><p>c) Can B. thetaiotaomicron utilize pseudovitamin B<sub>12</sub>, and – if so – how does the utilization (i.e. growth) compare to vitamin B<sub>12</sub>? Pseudovitamin B<sub>12</sub> is produced by select gut bacteria (i.e. Lactobacillus reuteri and Eubacterium hallii), food-associated microbes (i.e. Arthrospira platensis), or used as a food additive. Although pseudovitamin B<sub>12</sub> is another source of B<sub>12</sub>, it cannot be absorbed in the human GI tract (it does bind IF). If B. thetaiotaomicron can utilize pseudovitamin B<sub>12</sub> more efficiently than B<sub>12</sub>, then B. thetaiotaomicron would be beneficial for human health rather than detrimental, as the authors speculate in their Discussion (third paragraph).</p></disp-quote><p>We appreciate this useful point. We have previously shown that <italic>B. thetaiotaomicron</italic> can utilize [Ade]Cba (pseudovitamin B<sub>12</sub>); growth rates in minimal medium lacking methionine and supplemented with either [Ade]Cba or cyanocobalamin are equivalent (Degnan et al., 2014, Figure S3A). Others have reported that the binding affinity of IF to [Ade]Cba is an order of magnitude weaker than IF to B<sub>12</sub> (Fedozov et al., Eur J Biochem, 2003; Stupperich and Nexo, Eur J Biochem, 1991).</p><p>We are reluctant to speculate about the interactions between BtuG, IF and [Ade]Cba because we have not studied the interactions between these proteins and [Ade]Cba. We think that it is unlikely that BtuG2 acts as a “filter” to distinguish corrinoids, because it binds B<sub>12</sub> and cobinamide with similar affinity (Figure 3B). Thus, future studies will need to examine binding of diverse corrinoids (including those not commercially available) with many proteins in the corrinoid transport loci in addition to BtuG.</p></body></sub-article></article>